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FGF   fibroblast growth factor 
FRT   Fisher rat thyroid cells 
GAL4   positive regulator for the gene expression of the galactose 
induced genes of S. cerevisiae 
GFP   green fluorescent protein 
GLAST  glutamate aspartate transporter 
GPI   glycosylphosphatidylinositol 
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GST   glutathione-S-transferase 
GTP   guanosine triphosphate 
GTPase  GTP hydrolyzing enzyme 
HA   hemaglutinine 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
His   histidine 
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HIS-3   imidazoleglycerol-phosphate dehydratase, catalyzing the sixth 
step in histidine biosynthesis 
Hz   hydrazide 
IF   intermediate filament 
IgG   immunoglobulin G 
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MAL   myelin and lymphocyte protein 
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MT   microtubule 
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NGF   nerve growth factor 
NGS   normal goat serum 
Nr-CAM  neuronal cell adhesion molecule 
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null   null mutant 
o.n.   over night 
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OD   optical density 
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P#   postnatal day # 
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PDGF   platelet derived growth factor 
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PFA   paraformaldehyde 
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PMP22  peripheral myelin protein 22 
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PVDF   polyvinylidene difluoride  
RISC   RNA-induced silencing complex  
RNA   ribonucleic acid 
RNAi   small double-stranded RNA induced interferrence 
RT   room temperature 
SAP   shrimp alkaline phosphatase 
SCP   Schwann cell precursor 
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SDS-PAGE  sodium dodecyl sulfate polyacrylamide gel electrophoresis 
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SPF   specific pathogen free 
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WB   Western blot 
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3 Summary 
Rapid conduction of nerve impulses in the nervous system of higher vertebrates is 
made possible by ensheathment of nerve fibers by the specialized plasma membrane 
structure myelin. Consequently, failure of myelination or damage to the myelin sheath 
leads to severe pathology as seen in multiple sclerosis. During myelination 
oligodendrocytes and Schwann cells are challenged to build up and maintain a highly 
complex multilaminar plasma membrane structure. It is well-known that myelin 
membranes are divided into subdomains with distinct protein and lipid composition. 
Nevertheless, it is unclear how these domains are generated and then maintained 
throughout the adult. Especially the mechanisms of interaction between cytoskeleton 
elements and membrane structures in the developing and adult myelin sheath are still 
unknown. In this work, the interaction of the cytoskeleton protein septin 6 (Sept6) and 
the myelin and lymphocyte protein MAL is demonstrated. Septins are enriched in 
myelin membranes which is unique for cytoskeleton elements. Most important, the 
loss of Sept6 in myelin is compensated by its closest homolog Sept11 which clearly 
points to a functional role of septins in the myelin compartment. A detailed analysis of 
the septin protein family in myelinating cells was performed here. It was shown that 
septins are coordinately regulated during differentiation and myelination in Schwann 
cells and oligodendrocytes. On the protein level particular septins were identified to 
be differentially enriched in myelin membranes. They form distinct stoechiometric 
complexes interacting also with actin. We propose that septin/myelin membrane 
complexes play an important role in myelination. Septins might be crucial in the 
formation and maintenance of myelin subdomains as well as in the transport of 
myelin components. In line with this, a possible site of interaction between Sept6 and 
MAL was identified in the Schwann cell cytoplasm. There, Sept6 and MAL might be 
important for sorting and trafficking processes crucial for the targeting of myelin 
components into the emerging and adult myelin sheath. Sept6-deficient mice, 
however, did not disclose alterations in myelin ultrastructure and protein composition 
besides the upregulation of Sept11. But, it is well-known that the septin cortex is very 
robust and that homologous isoforms might compensate for the loss of single septins. 
In line with this, it is shown here that myelinating Schwann cells tolerate the loss of 
Sept2, which might be due to such compensation mechanisms. The function of Sept7 
in myelination could not be elucidated, since downregulation in in vitro myelinating 
cultures led to unspecific effects probably on cytokinesis and cell survival. 
Nevertheless, this first comprehensive study on septins in oligodendrocytes and 
Schwann cells generated valuable data critical for further analysis of septin function 
in myelin. This study provides insight into the composition of the septin cytoskeleton, 
its regulation during myelination and its interaction with myelin membranes. 
Understanding the role of the septin cytoskeleton in myelin formation and 
maintenance may reveal new insights in the mechanisms of myelination and 
remyelination in health and disease. 
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4 Introduction 
4.1 From polarized transport to the mature myelin sheath 
Myelination is the basis for fast and efficient conduction of nerve impulses in the 
nervous system of higher vertebrates. The myelin sheath is a uniquely complex and 
elaborate plasma membrane structure interacting with nerve processes, the axons. 
Its morphological buildup goes far beyond the imagination of what a single cell is 
capable of doing perhaps only comparable with the generation of axons of long-
projecting motor neurons. Despite of decades of research it is still largely unknown 
how myelinating cells succeed in constructing and maintaining the myelin sheath. 
Recently, parallels of differential sorting and trafficking of membrane components in 
polarized epithelial cells and myelinating cells were appreciated. The concepts of 
polarized transport mechanisms in myelinating cells are, therefore, avidly discussed. 
Especially the role of cytoskeleton elements in this respect is matter of interest since 
these elements are crucial for all transport processes but also for the structuring of 
membranes. In this work, the role of a cytoskeleton protein family, the septins, in 
myelinating cells is described. 
 
4.2 Myelin 
4.2.1 Myelination 
Rapid conduction of nerve impulses in the nervous system of higher vertebrates is 
made possible by ensheathment of nerve fibers by the specialized plasma membrane 
structure myelin. Myelinating cells wrap plasma membrane extensions up to 50 fold 
around the axon and tightly pack the respective membrane layers excluding the 
cytoplasm. The resulting insulation minimizes loss of electrical signals caused by 
transverse diffusion. Additionally, ion channels contributing to the propagation of the 
action potential are clustered at specialized axonal segments, the nodes of Ranvier, 
lowering the energy demand for action potential firing (Waxman and Ritchie, 1993). In 
consequence faster and more efficient nerve conductance is achieved with smaller 
axon diameters (for review see Waxman, 1980). This is indeed important for the built 
up of the nervous system of higher vertebrates since myelinated fast firing nerves can 
be more tightly packed than non-myelinated fibers which axon diameters have to be 
much larger to reach comparable conduction velocities. Consequently, failure of 
myelination or damage to the myelin sheath results in slowed signal propagation or 
even conduction block leading to severe pathology as seen in multiple sclerosis and 
other primary demyelinating diseases.  
During myelination, oligodendrocytes and Schwann cells are challenged to build up 
and maintain a highly complex multilaminar plasma membrane structure. This implies 
changing the expression pattern of multiple genes with the prominent upregulation of 
a distinct myelination program as well as redistribution of cytoskeleton elements and 
polarization of the membrane structures. Indeed Schwann cells and oligodendrocytes 
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establish and maintain distinct membrane subdomains with different protein and lipid 
content (Kim and Pfeiffer, 1999; Simons et al., 2000). A schematic overview about the 
different myelin compartments with some of the molecules that are specifically 
enriched in either domain is illustrated in Figure 1. Myelin structure and domains are 
introduced in detail in chapter 4.3. The rate of membrane production in the period of 
highest myelinating activity demands specialized cytoskeleton elements for trafficking 
and transport of vesicles as well as structural support for the emerging myelin sheath. 
Many aspects concerning the process of myelination are still unclear. Recently, 
concepts of how distinct subdomains contributing to functionality along myelinated 
axons are generated are emerging (for review see Poliak and Peles, 2003; Salzer, 
2003).  
 
 
 
 
Figure 1 Schematic drawing of a myelinated nerve segment in the PNS 
(A) The membrane compartment of a myelinating Schwann cell is presented as “enrolled” sheath. 
Different subcompartments like the compact myelin and the non-compact myelin, the incisures and the 
paranodes, are depicted. (B) Both the compact as well as the non-compact myelin compartments have 
distinct sets of molecules selectively enriched. The major myelin proteins are discussed in more detail 
in chapter 4.3.2 (copied from Arroyo and Scherer, 2000). 
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4.2.2 Myelinating cells 
The myelinating cells of the central and peripheral nervous system, the 
oligodendrocytes and Schwann cells respectively are basically confronted with a very 
similar task. Although there are differences in respect of how these cells enwrap the 
axons, the structural outcome is very comparable (Figure 2). Both cell types need to 
synthesize vast amounts of myelin membrane with the respective proteins and lipids, 
correctly target and transport the building blocks and integrate them into the 
emerging myelin sheath. This process involves an orchestrated interplay of vesicular 
transport systems with the cytoskeleton tracks and scaffolds to target the respective 
structures. After completion of myelination the myelin sheath has to be conserved 
throughout live respecting the established subdomains and compartments. 
 
 
 
 
 
Figure 2 Myelinating cells 
Oligodendrocytes in the CNS and Schwann cells in the PNS myelinate fast conducting axons. 
Oligodendrocytes are capable of forming multiple myelin sheaths whereas Schwann cells form one 
single myelinated internode (copied from Poliak and Peles, 2003). 
Introduction 
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4.2.2.1 Oligodendrocytes 
Oligodendrocytes derive from pluripotent glial precursor cells generated in restricted 
regions of the neural tube (Warf et al., 1991), and then precede through a 
differentiation program that will ultimately lead to myelinating oligodendrocytes 
(Figure 3). The first identifiable glial precursors, the glial restricted precursor cells, 
can be isolated from the entire rostrocaudal axis. From there they proceed to 
progressively more restricted precursor cells. The earliest well characterized cell of 
the oligodendrocyte lineage are bipolar A2B5+ precursors (Raff et al., 1984). They 
are critically dependant on PDGF as their major growth factor. In fact, high 
expression of PDGFαR is a marker for the oligodendrocyte lineage (Pringle et al., 
1992). Correct number of progenitor cells is controlled by regulating cell proliferation 
and survival (Barres et al., 1992). These immature so-called O2A progenitors still 
show stem cell like characteristics in that they can give rise to all neural cell types, in 
particular oligodendrocytes, astrocytes and neurons (Kondo and Raff, 2000). During 
maturation the A2B5+ cells begin to express the O4 antigens e.g. galactosulfatite but 
retain their bipolar morphology (Pfeiffer et al., 1993). The next stage is characterized 
by a loss of precursor antigens (e.g. A2B5) and the expression of galactocerebroside 
detectable as O1 antigens (Raff et al., 1978). O1+ cells stop proliferation and gain a 
multibranched morphology (Figure 3, premyelinating oligodendrocyte). At this stage 
they are determined into the oligodendrocyte fate and will ultimately mature or 
undergo apoptosis (Barres et al., 1992). Continuing maturation, they begin to express 
the first myelin genes such as MBP and PLP and elaborate their membrane sheaths; 
in vivo they will begin to form multiple internodes (Figure 2). Finally, mature 
oligodendrocytes are characterized by high expression of late myelin genes like MOG 
or MAL (Schaeren-Wiemers et al., 1995; Scolding et al., 1989). Importantly, 
oligodendrocytes can undergo most of their maturation program autonomically. They 
can express all major myelin genes in pure cultures without neurons, and build large 
membranes with normal myelin protein composition (Pfeiffer et al., 1993). 
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Figure 3 The oligodendrocyte lineage 
Oligodendrocytes derive from pluripotent progenitor cells. During differentiation they proceed from 
early to late progenitors and premyelinating oligodendrocytes. The premyelinating oligodendrocyte will 
either myelinate or undergo apoptosis if they are not associated with an axon (adapted from Trapp et 
al., 1997). 
 
 
4.2.2.2 Schwann cells 
Schwann cell precursor cells (SCPs) are generated from neural crest cells (Figure 4). 
From there they migrate along the developing peripheral nerves in intimate contact to 
the axons. The survival of SCPs is critically dependant on axonal derived signals like 
neuregulin-1 type III (Garratt et al., 2000). Conversely, SCPs seem to provide axons 
with survival factors important for both sensory and motor neurons (Britsch et al., 
2001; Riethmacher et al., 1997). SCPs seem to be unifated in that they are destined 
to become only Schwann cells in normal development. The transition of SCPs to 
Schwann cells was determined to peak at E16 in rodents. Mature Schwann cells have 
lost their extrinsic dependency on neuregulin for survival and  established autocrine 
survival circuits (Jessen et al., 1994; Meier et al., 1999). Following this, the immature 
Schwann cell intermediate stage splits into the future myelinating Schwann cells and 
non-myelinating Schwann cells. The myelinating Schwann cells form a one-to-one 
relationship to axons and ultimately myelinate. At this stage of development, 
neuregulin-1 type III expressed on the axons triggers myelination and regulates 
Schwann cell membrane growth and, thus, myelin sheath thickness to match the 
axon caliber (for review see Nave and Salzer, 2006). Non-myelinating Schwann cells 
ensheathe a bundle of smaller caliber axons with a double plasma membrane layer 
the so-called Remark bundles (for review see Jessen and Mirsky, 1999). In this 
respect the fate of the Schwann cell is determined by the axon that is associated and 
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instructs the glia cell either to myelinate or not. As mentioned, Schwann cells loose 
their extrinsic dependency on axonal signals and can, therefore, also survive and 
dedifferentiate after loss of their axon. This ability enables Schwann cells to 
remyelinate regenerating peripheral nerves after injury (Fawcett and Keynes, 1990). 
In vitro, Schwann cells do not differentiate autonomously like oligodendrocytes. The 
transcription factor Krox20 which is the main instructor for the myelination program is 
only expressed upon contact with axons (Nagarajan et al., 2001; Parkinson et al., 
2002; Zorick et al., 1996; Zorick et al., 1999). Therefore, isolated Schwann cells do 
not express myelin markers and dedifferentiate in culture to gain a SCP like stage. 
 
 
 
Figure 4 The Schwann cell lineage 
Schwann cells derive from neural crest cells. They migrate along the peripheral nerve tracts as 
Schwann cell precursors. At E18 immature Schwann cells populate the entire length of peripheral 
nerves in intimate contact with axons. Depending on the axon the Schwann cell will either myelinate or 
form Remark bundles of non-myelinated axons (copied from Jessen and Mirsky, 1999). 
 
4.3 Myelin structure and function 
The myelin sheath critically depends on its complex structure for normal function (for 
review see Poliak and Peles, 2003; Salzer, 2003). During myelination the respective 
glial cells wrap their plasma membranes around the axons. During this process, the 
cytoplasm between the membrane layers is excluded leading to a compact packing of 
both the intracellular and extracellular leaflets of the membranes visible by electron 
microscopy (Figure 5). The cytoplasmic leaflets contact to form the major dense line 
whereas the packed extracellular leaflets form the minor dense lines. Consequently, 
the compact myelin sheath is seen in cross section as a circular consecution of 
electron dense (major dense line) and light lines (minor dense line or intraperiod line). 
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Besides the compact myelin compartment (Figure 6A) which makes up the majority of 
the myelin sheath also several non-compact myelin compartments exist (Figure 6B 
and C). At the lateral ends where opposing internodes form the nodes of Ranvier, the 
myelin membranes split up to form cytoplasm filled paranodal loops attaching to the 
axons (Figure 6B). The adaxonal compartment, the innermost membrane wrap 
contacting the axon, also comprises cytoplasmic channels possibly enabling signal 
transduction between axon and glia. Finally, in the PNS the compact myelin is 
interrupted by cytoplasmic channels spiraling down to the axon, the Schmidt-
Lanterman incisures (Figure 6C). In addition, Schwann cells form a snake-skin like 
network of cytoplasmic channels surrounding the myelin sheaths known as the Cajal 
bands (Court et al., 2004). The non-compact myelin compartments are believed to be 
important for nourishing the myelin sheath as well as providing structural components 
and signaling platforms for axon-glia crosstalk. 
 
 
 
Figure 6 The compact and non-compact myelin compartments of a myelin sheath 
The myelin sheath is composed of compact and non-compact myelin compartments. (A)The majority 
of the internode is compact myelin. (B) At the lateral ends of the internodes the myelin membranes 
split up to form cytoplasm filled paranodal loops and microvilli. (C) Schwann cells also form regions of 
non-compact myelin, the Schmidt-Lanterman incisures, within compact myelin domains. 
Figure 5 The ultrastructure of the myelin sheath
A cross-section of a myelin sheath is visualized 
by electron mycroscopy. The compact myelin 
structure (m) is composed of alternating major 
dense and intraperiod lines (copied from Revel 
and Hamilton, 1969). 
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Oligodendrocytes are capable of forming multiple internodes each of which is formed 
by one plasma membrane extension. Depending on the region and type of 
myelinated axons, oligodendrocytes myelinate between few to up to 40 axons. 
Interestingly, they seem to be capable of recognizing the “future size” of their target 
axons. This is of importance since large caliber axons also acquire thicker myelin 
sheaths. Oligodendrocytes myelinating large caliber axons (e.g. in the brainstem) will 
form fewer internodes whereas oligodendrocytes myelinating small caliber axons as 
in the optic nerve will form many internodes (Fanarraga et al., 1998). 
Oligodendrocytes do not form Cajal bands but have a single longitudinal cytoplasmic 
channel along the whole myelin sheath connecting the perinuclear and paranodal 
cytoplasm. This channel contains microtubules, mitochondria, smooth endoplasmic 
reticulum and vesicles. Schwann cell internodes are distinct from oligodendrocyte 
internodes not only by having Schmidt-Lanterman incisures and Cajal bands. In 
contrast to oligodendrocytes Schwann cells form a complex extracellular matrix, the 
basal lamina, containing laminins and collagens (Bunge, 1993; Scherer, 1996). The 
outmost lateral loops of the Schwann cell membrane form microvilli contacting the 
nodal axolemma (Ichimura and Ellisman, 1991; Raine, 1982). Microvilli have a 
distinct set of ion channels and structural components which might be necessary for 
forming functional nodes of Ranvier and for normal electrical signal processing 
(Devor et al., 1993; Howe and Ritchie, 1990).  
 
4.3.1 The nodes of Ranvier 
The nodes of Ranvier were already appreciated 1928 by Ramón y Cajal by silver 
staining and described to comprise different compartments (Cajal, 1928). Both CNS 
and PNS nodes of Ranvier fulfill the same function but still are not identical in terms 
of ultrastructure. The nodes of Ranvier can be subdivided into three parts crucial for 
the renewal of the action potential: the nodal, paranodal and juxtaparanodal regions 
(Figure 7A). At the centre or nodal region voltage-gated sodium channels are 
clustered and ultimately are responsible for propagation of the action potential 
(Ellisman and Levinson, 1982). The clustering of sodium channels critically depends 
on intact nodal architecture (Rios et al., 2003; Rosenbluth et al., 2003). The axonal 
segment underlying the node is highly specialized with a distinct submembranous 
cytoskeleton containing spectrin, f-actin and ankyrin (Arroyo and Scherer, 2000; 
Kordeli et al., 1990). Additionally, adhesion molecules like Nr-CAM and 
Neurofascin186 are clustered at the node and seem to interact with glial proteins in 
the microvilli (for review see Poliak and Peles, 2003). Since oligodendrocytes are not 
forming microvilli, the CNS nodes are not covered by oligodendrocyte membranes. 
Instead, glial processes formed by astrocytes contact the nodes but do not form 
tightly adherent structures like seen in the PNS nodes (Black and Waxman, 1988). 
At the lateral end of compact myelin the tight membrane packing is split up to form 
the paranode. Cytoplasm filled loops contact the paranodal axolemma stabilized to 
the axon and each others by junction complexes (Figure 7B). At the contact site of 
paranodal loops with the axolemma septate-like junctions are formed which are 
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believed to enforce the adhesion of the opposing membranes (Bhat et al., 2001; 
Boyle et al., 2001). On the axonal site a complex of the adhesion molecules Caspr 
and contactin accumulate at the paranode where they are proposed to interact with 
glial Neurofascin155 in the paranodal loops. 
The tight junction between the paranodal loops and the axolemma seem to have a 
function in restraining potassium channels to the juxtaparanode but not on clustering 
sodium channels at the nodal region (for review see Mitic and Anderson, 1998). 
Paranodal loops are comparable to other non-compact myelin compartments like 
Schmidt-Lanterman incisures, but contain more cytoplasm and have a complex 
cytoskeleton scaffold. 
The juxtaparanode cannot be identified as morphological structure, but is defined as 
10-15 nm wide area adjacent to the paranode. Functionally important is the clustering 
of delayed rectifying potassium channels, which are important for the excitability of 
the nodes (Rasband et al., 1998). With the exception of some molecular components, 
the juxtaparanodes do not differ much from the remaining internodal region. 
 
 
 
 
 
Figure 7 The node of Ranvier 
(A) The compartments of the node of 
Ranvier, the nodal, the paranodal and 
juxtaparanodal regions are depicted. 
(B) A complex set of adhesion 
molecules, cytoskeleton elements and 
membrane receptors are important for 
nodal integrity and correct localization 
of ion channels (copied from Arroyo 
and Scherer, 2000). 
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4.3.2 Myelin proteins 
The myelin membrane comprises a regular consecution of membrane layers with 
defined periodicity. Clearly, there must be organizing elements integrating into the 
compact myelin layers to mediate the adhesion of the membranes. Interestingly, the 
total myelin protein content is represented to very large proportions by a small 
number of major myelin proteins. They are believed to determine the ultrastructural 
constants of the myelin spirals as defining the intraperiod line or the major dense line.  
 
4.3.2.1 MBP, PLP and P0 
Myelin accounts for 20-25% of the dry weight of the brain. The myelin basic protein 
(MBP) together with proteolipid protein (PLP) account for 80% of the total protein 
content in myelin (Braestrup and Squires, 1977; Squires and Brastrup, 1977). PLP is 
largely specific for CNS myelin (Trotter et al., 1981), whereas protein zero (P0) is 
exclusively expressed in PNS myelin where it comprises 60% of total protein 
(Greenfield et al., 1973). Because of their abundance these were among the first 
myelin proteins analyzed in the nervous system (Takahashi et al., 1985). It was 
evident from studies with specific antibodies that both MBP and PLP are exclusively 
localized to myelin (Agrawal et al., 1977; Hartman et al., 1982). 
The primary function of these three proteins is believed to be to support the structure 
of the myelin sheath. P0 seems to stabilize the intraperiodal line in PNS myelin. This 
is achieved by homophilic interaction of P0 molecules from adjacent membrane 
layers. High resolution structure of P0 suggests that it may form a tetramer on the 
membrane which can then interact with a second tetramer from the apposing 
membrane layer (Shapiro et al., 1996).  
PLP and its alternatively spliced minor isoform DM20 contributes to 50-60% of the 
total CNS intra-membrane protein and is, therefore, an excellent candidate for 
structural maintenance in myelin. Nevertheless, PLP/DM20-deficient mice show only 
very subtle phenotypes (Garbern et al., 1999). In contrast, a PLP/DM20 and 
OSP/Claudin-11 double-deficient mouse line has severe neurological deficits and 
markedly abnormal myelin compaction (Chow et al., 2005) which was not obvious in 
the single null mice. OSP/Claudin-11 and PLP are both structurally related tetraspan 
proteins and might therefore compensate for the loss of each other. 
MBP owes its name to the fact that it contains a very high percentage of basic 
residues which are believed to be important for the interaction with the phospholipids 
of the membrane. MBP might be necessary for compaction and maintenance of the 
myelin sheath by connecting the inner leaflets of myelin membranes (Omlin et al., 
1982). However, this role of MBP is questioned since a spontaneous mutation in the 
MBP locus, resulting in almost complete absence of MBP, can still form grossly 
normal myelin structures in the PNS (Kirschner and Ganser, 1980). Data from other 
studies suggest that MBP might interact with cytoskeleton elements which will be 
discussed later. Interestingly, MBP mRNA was shown to be distributed along 
myelinated internodes, whereas transcripts encoding for PLP and P0 remain 
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localized around the nuclei of the myelinating cells (Trapp et al., 1987). Further 
studies in oligodendrocyte cell cultures demonstrated that MBP mRNA gradually 
moved into the oligodendrocyte processes over time. Later experiments showed that 
MBP is synthesized on free polysomes very close to where it is incorporated into the 
myelin. 
Taken these data together the exact role of the major myelin proteins MBP, PLP and 
P0 is still not fully understood. Seemingly, compensation mechanisms masking loss 
of function mutation hinder the analysis of myelin proteins tremendously. 
 
4.3.2.2 MAG and MOG 
MAG is the major CNS glycoprotein and thought to be involved in neuron-glia 
interaction. Both MAG and MOG belong to the Ig superfamily of proteins which 
potentially interact with carbohydrates of target structures. MAG is expressed upon 
first contact with axons (Quarles, 1983) and is subsequently upregulated towards 
myelination. MAG is restricted to non-compact myelin including the periaxonal 
location. A number of studies implicated MAG in the development, maintenance and 
repair of the myelin sheath and axon-glia interaction. Seemingly, MAG might have a 
role in axon glial interaction during development and in the adult (Sternberger et al., 
1979). Alternative splicing gives rise to two MAG isoforms, the large L-MAG and the 
short S-MAG. Besides having properties of a cell adhesion molecule, MAG might also 
be a transmembrane receptor. L-MAG is thought to be able to signal extracellular 
cues to the inside since L-MAG has phosphorylation sites, but their precise function is 
not known. Interestingly, S-MAG binds tubulin potentially linking the axonal surface to 
the glial cytoskeleton (Kursula et al., 2001). It was also shown that the microtubule 
associated protein MAP1B can bind to MAG (Franzen et al., 2001) strengthening the 
concept that MAG might be important for cytoskeleton interactions. MAG-deficient 
mice are viable but show a delay in CNS myelination (Bartsch et al., 1997; Li et al., 
1994; Montag et al., 1994) and subtle defects in normal myelin structure as well as 
secondary effects on neurons. Although MAG was intensely investigated, its exact 
role in development and in the adult is still matter of debate. 
 
MOG was discovered as an immunological target in experimental autoimmune 
encephalomyelitis (EAE). It was further recognized that MOG is a glycoprotein 
expressed by oligodendrocytes (Linington et al., 1984). Immunization against MOG is 
frequently used as a model for inflammatory demyelinating diseases like multiple 
sclerosis. MOG is a minor constituent of CNS myelin and has some features that 
clearly distinguish it from the major myelin components MBP, PLP and MAG. MOG 
localizes exclusively to the outermost surface of the oligodendrocyte membrane 
structures (Brunner et al., 1989). The topographic organization of MOG in the lipid 
bilayer was for long a matter of debate. Kroepfl and colleagues demonstrated in 1996 
that MOG is a type I transmembrane protein. Although containing two potential 
transmembrane domains only one spans the plasma membrane (Kroepfl et al., 
1996). Later work suggested that the second hydrophobic region is interacting with 
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the plasma membrane leaving two short cytoplasmic stretches (della Gaspera et al., 
1998). The extracellular loop of MOG was modeled and predicts a Ig-like domain 
(Hjelmstrom et al., 1998; Mesleh et al., 2002). It is believed that MOG might be 
important as an adhesion molecule since it is highly enriched on the surface of the 
myelin sheath. There, it might interact with the extracellular matrix or mediating 
adhesion between neighboring myelinated axons (for review see Schachner and 
Martini, 1995). Nevertheless, MOG-deficient mice do not show a phenotype despite 
insensitivity to MOG-mediated EAE (Delarasse et al., 2003). Interestingly, there might 
be a link between MOG and microtubular integrity since treatment with anti-MOG 
antibodies can lead to depolymerization of microtubules in oligodendrocytes (Dyer, 
1993; Dyer and Benjamins, 1990; Dyer and Matthieu, 1994). These results are in line 
with speculations about potential receptor functions of MOG. Besides being an Ig-like 
protein, its raft association points to a role in signaling cascades (Lisanti et al., 1995). 
There, it might be involved in lipid/protein sorting as well as in signal transduction 
pathways (Kim and Pfeiffer, 1999). 
 
4.3.2.3 MAL 
MAL is a highly hydrophobic proteolipid that was first discovered in cells of the 
immune system, the T-lymphocytes (Alonso and Weissman, 1987). MAL is 
expressed in intermediate and late stage T-cells. Its name derived from the fact that it 
was identified as being expressed by both MOLT-4 (stage II thymocytes) and HPB-
ALL lymphocyte cells (stage II/III). Later, differential screens identified MAL being 
expressed in rat primary oligodendrocytes (Kim et al., 1995; Schaeren-Wiemers et 
al., 1995) and in polarized epithelial cells (Frank, 2000; Magyar et al., 1997; Zacchetti 
et al., 1995). The already introduced abbreviation “MAL” was further used as myelin 
and lymphocyte protein (Schaeren-Wiemers et al., 1995). Its strongest expression is 
found in myelinating cells both of the CNS and PNS, and the MAL protein is 
incorporated into compact myelin as a minor myelin protein (Frank et al., 1998). 
Interestingly, MAL was also shown to be present in non-compact myelin structures 
which differs from the major myelin proteins MBP, PLP and P0 (Erne et al., 2002). 
First insights into the potential molecular functions of the MAL protein derived from 
the fact that MAL is incorporated into glycolipid-enriched membrane fractions the so-
called rafts (Frank et al., 1998; Kim et al., 1995; Martin-Belmonte et al., 1998; Millan 
et al., 1997; Zacchetti et al., 1995). Zacchetti and colleagues localized MAL in 
vesicular structures in the apical cytoplasm of polarized Madin-Darby canine kidney 
(MDCK) cells and proposed that MAL might be a candidate component in vesicular 
trafficking systems (Zacchetti et al., 1995). In polarized tissue like kidney and 
stomach epithelial, MAL is localized exclusively on the apical surface of the cells 
suggesting a role of MAL in raft dependant polarized sorting and trafficking 
mechanisms (Frank et al., 1998). In line with these findings, alterations of MAL levels 
in MDCK cells had effects on protein and membrane transport (Cheong et al., 1999). 
The role of MAL in polarized sorting is discussed in more detail in chapter 4.4.3. 
Introduction 
   
24 
In the nervous system MAL is expressed both in oligodendrocytes and Schwann cells 
(Schaeren-Wiemers et al., 1995). Interestingly, the timing of expression during 
development is different in the CNS compared to the PNS pointing to distinct 
functions in both systems (Frank et al., 1999). In oligodendrocytes MAL is expressed 
late during myelination. It appears several days after the onset of MBP and PLP 
expression and probably coincides with the expression of the late myelin marker 
MOG. In the PNS MAL is already expressed embryonically (E17) in Schwann cell 
precursors long before myelination initiates. This suggests that MAL might have a 
function in Schwann cell differentiation (Schaeren-Wiemers et al., 1995). Both MAL- 
deficient and MAL-overexpressing mice were generated and analyzed for defects in 
CNS and PNS myelination (Frank et al., 2000; Schaeren-Wiemers et al., 2004). In 
both models overall myelin formation appeared normal. Nevertheless, distinct 
phenotypes appeared both in the CNS and the PNS. In MAL-deficient mice a defect 
was described for the CNS nodes of Ranvier. The paranodal loops were found to be 
detached from the nodal axolemma and the electron dense protein accumulation 
known as septate junctions were lost from some paranodal loops but not all. Most 
strikingly, the paranodal marker Caspr was dispersed in MAL-deficient mice 
compared to clusters in the wild type animals (Schaeren-Wiemers et al., 2004). 
Suggested function from other cell types indicate that MAL might be important to 
target specific components which are important for axon-glia interaction to the 
paranodal loops, and therefore, maintain the integrity of the junctions. The PNS 
nodes of Ranvier were seemingly not altered. MAL-overexpressing mice, in the PNS, 
showed a defect in axonal sorting (Frank et al., 2000) and in the regulation of 
myelination initiation (Schaeren-Wiemers, unpublished). These effects are not yet 
understood but might be attributed to a signaling defect in MAL-overexpressing mice 
due to altered lipid raft composition. Clearly, the role of MAL is best understood in 
polarized sorting mechanisms. These results may be applicable to the myelinating 
glia. Yet, the exact role of MAL influencing sorting and trafficking in oligodendrocytes 
and Schwann cells has to be demonstrated. Undoubtedly, these processes involve 
cytoskeleton elements. Therefore, the identification of the link between the raft 
associated protein MAL and the cytoskeleton might reveal new concepts of how MAL 
and related lipid raft associated proteins exert their function on the molecular level. 
 
4.4 Polarized cells 
The concept of polarized transport and trafficking mechanisms originates from and is 
best studied in epithelial cells but was adapted to approach the generation of distinct 
subdomains in myelinating cells. Here, models of raft-dependant and independent 
polarized transport machineries will be introduced. First, the concept of membrane 
rafts, and subsequently, polarized transport mechanisms and their importance in 
myelinating cells will be discussed. 
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4.4.1 Membrane rafts 
Particular aspects of polarized sorting mechanisms depend on detergent-insoluble 
glycolipid-enriched complexes (DIGs) or glycolipid-enriched microdomains (GEMs) 
floating within the plasma membrane and, therefore, called membrane rafts. For 
decades membrane bilayers were thought to be unstructured and that membrane 
bound molecules were able to diffuse unconfined in the two-dimensional membrane 
plane (Singer and Nicolson, 1972). However, it became evident that not only different 
lipid species are asymmetrically distributed between the cytoplasmic leaflet and the 
exoplasmic leaflet of the membrane (Simons et al., 2000; van Meer and Simons, 
1988) but there is also a lateral structuring in the two-dimensional lipid plane (Kusumi 
and Sako, 1996). In this view, specific lipids form clusters together with cholesterol 
into micro-domains, the membrane rafts, which display different physico-chemical 
properties compared to the surrounding plasma membrane. The proposed 
spingolipid/cholesterol raft is described as follows (Figure 8). Sphingolipids associate 
laterally and form lipid clusters. Their head groups occupy more space than their 
hydrocarbon chains. Consequently, voids are formed in the membrane bilayer which 
are filled by cholesterol (Simons and Ikonen, 1997). These densely-packed 
spingolipid/cholesterol assemblies may serve as platforms for specific protein 
transport and for intracellular and transmembrane signaling. In the last years 
considerable dispute emerged about the issue if rafts exist also in vivo or if they are 
an isolation artifact (for review see Munro, 2003). In a recent Keystone Symposium 
on membrane rafts the following consensus definition emerged: ”Membrane rafts are 
small (10-200nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched 
domains that compartmentalize cellular processes. Small rafts can sometimes be 
stabilized to form larger platforms through protein-protein and protein-lipid 
interactions” (Pike, 2006). Today, rafts are considered to be organizing platforms for 
diverse cellular functions like cell adhesion, signaling, sorting and trafficking 
processes.  
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Figure 8 Schematic illustration of membrane rafts 
Membrane or lipid rafts are specialized structures floating in the membrane bilayer. Sphingolipids 
associate laterally and incorporate cholesterol to form membrane rafts. Particular membrane bound 
proteins can enrich specifically in membrane rafts (adapted from Anderson and Jacobson, 2002 and 
NIGMS, 2005). 
 
4.4.2 Polarized sorting and trafficking mechanisms 
The plasma membrane of epithelial cells is polarized into an apical and a basolateral 
compartment (Einarson et al., 1982 and Figure 9). These membrane domains exert 
different functions reflected also in a different protein and lipid composition. The 
apical domain is enriched in sphingolipids whereas the basolateral domain has a high 
content of glycerolipids and phosphatidylcholine (Simons et al., 2000; van Meer, 
1989). The two domains are separated physically by diffusion restricting tight 
junctions at their interface. How these distinct domains are generated and maintained 
in terms of transport and integration of newly synthesized components is issue of 
intense studies. Epithelial cells have two distinct transport mechanisms both 
contributing to generate polarity, a direct pathway and an indirect pathway (Mostov et 
al., 1992; Weimbs et al., 1997). The direct pathway integrates apical and basolateral 
proteins into separate transport vesicles and directly delivers them to their respective 
compartment (Figure 9). The indirect pathway sorts both apical and basolateral 
components to the basolateral membrane and subsequently redirects apical proteins 
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to the apical membrane by specific transcytosis (Figure 9). The signal for sorting 
transmembrane proteins to either compartment is intrinsic to the respective proteins. 
Basolateral sorting signals are usually integrated into the cytoplasmic domain of the 
proteins but also their tertiary structure can provide the targeting information (Matter 
and Mellman, 1994). The GPI anchor is the best described targeting signal 
integrating GPI-anchored proteins into apically sorted rafts (Brown and Rose, 1992; 
Simons and Ikonen, 1997). Besides this, also the transmembrane segments can 
promote membrane raft association and apical targeting (Barman and Nayak, 2000). 
Also N- and O-linked oligosaccharides and specific amino acids may function as 
apical sorting signals (Benting et al., 1999; Rodriguez-Boulan and Gonzalez, 1999). 
Microtubules and microfilaments as well as motor proteins from the kinesin and 
dynein family are important to translocate the transport vesicles for both direct and 
indirect pathways (Hirokawa, 1998; Kamal and Goldstein, 2000). After having 
reached its destination the transport vesicle fuses using specific recognition and 
fusion machineries. Besides proteins, also lipids integrate differentially into different 
membrane domains. It was appreciated that newly synthesized sphingolipids were 
preferentially transported to the apical membrane (Simons et al., 2000). Based on 
this it was proposed that glycosphingolipids specifically cluster in the Golgi 
membrane and are then transported to the apical surface. Along with them, proteins 
destined for the apical plasma membrane may be co-transported to their target 
compartment. Additionally, clustered glycosphingolipids together with cholesterol 
(membrane rafts) are present in caveolae, small invaginations of the plasma 
membrane devoid of clathrin coats. These caveolae might have a role in endocytosis 
and transcytosis both of which are important for basolateral sorting processes 
(Ghitescu et al., 1986; Tran et al., 1987). Therefore, sphingolipid membrane rafts 
seem to be involved in membrane trafficking. 
 
 
 
 
 
Figure 9 Scheme of polarized cells 
Polarized cells feature an apical and a 
basolateral membrane domain separated 
by tight junctions (black ellipses). The 
direct pathway sorts components from the 
trans-Goligi network (TGN) directly to their 
respective domain. Endocytotis and 
transcytosis remove components from the 
membrane and can redirect them to the 
correct localization (indirect pathway). 
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In myelinating cells sorting and transport mechanisms are investigated and are 
considered to stand in the center of understanding how myelin internodes are 
generated and maintained. Importantly, myelin proteins have targeting sequences 
which are functional in polarized sorting in epithelial cell lines. As example the large 
isoform of MAG (L-MAG) was targeted to both apical and basolateral compartments, 
whereas the short isoform S-MAG was targeted to the apical domain of MDCK cells 
(Minuk and Braun, 1996). For MOG, a potential basolateral sorting signal was 
identified and indeed MOG is targeted to the basolateral compartment in MDCK cells 
(Kroepfl and Gardinier, 2001). In contrast, PLP is integrated into the apical domain 
and a 13 amino acids signal sequence at its N-terminus is sufficient to target LacZ to 
the myelin sheath in vivo (Kroepfl and Gardinier, 2001; Wight et al., 1993). 
Controversially, P0 was targeted not to the apical but to the basolateral domain in 
MDCK cells, and deletion of its cytoplasmic domain led to apical targeting. The latter 
results demonstrate that the situation of myelinating cells cannot be easily modeled in 
simple polarized epithelial cells. Therefore, the identified signal sequences must be 
studied during the process of myelination itself. Up to day little is known about the 
specific molecules and their interactions in sorting and targeting machineries in 
myelinating cells. Therefore, concepts established in other cells are used to speculate 
about the situation in oligodendrocytes and Schwann cells. 
Some studies provided evidence how proteins are sorted and transported in PNS 
internodes. Trapp and colleagues analyzed the targeting of P0 (compact myelin), 
MAG (non-compact myelin) and laminin (plasma membrane) to their respective 
domain (Trapp et al., 1995). First, they demonstrated that P0 and MAG were 
incorporated into different transport vesicles as they exit from the TGN and were 
transported along the internode on microtubules. Furthermore they showed that P0 
and MAG were not mistargeted upon disruption of microtubules but accumulated in 
the cytoplasm as distinct entities (Trapp et al., 1995). They conclude that 
microtubules have no direct role in targeting of distinct vesicles but that most likely 
specific ligand receptor interaction at the target domains is responsible to correctly 
incorporate respective vesicles. 
 
4.4.3 MAL in polarized epithelial cells 
As described in chapter 4.3.2.3, MAL was identified to be present in membrane rafts 
of vesicular structures in the apical cytoplasmic domain of MDCK cells (Zacchetti et 
al., 1995). Therefore, it was speculated that MAL might have a role in polarized 
sorting and transport mechanisms. Interestingly, if overexpressed in insect cells MAL 
caused the formation of intracellular vesicles. This suggests that MAL might have a 
role in formation of glycolipid-enriched vesicles (Puertollano et al., 1997). Following 
this, several functional experiments led to the conclusion that, indeed, MAL is crucial 
for sorting and transport of apical components. Cheong and colleagues analyzed the 
effect of altering MAL levels in MDCK cells by overexpression and antisense 
techniques. They stated that increased levels of MAL led to increased apical 
transport and expansion of the apical surface (Cheong et al., 1999). In contrast, 
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reduced levels of MAL caused accumulation of apical surface markers like the 
influenza virus hemaglutinin (HA) in the post-Golgi compartments. The basolateral 
surface marker E-cadherin was not influenced leading to the concept that MAL must 
be important for apical transport mechanisms. Another study analyzed the role of 
MAL in Fischer rat thyroid (FRT) cells. These cells sort GPI-linked proteins to their 
basolateral compartment under normal conditions. Also in these FRT cells the correct 
transport of apical markers was dependant on normal MAL levels independent if they 
were raft associated or not (Martin-Belmonte et al., 2000). Frank and colleagues draw 
the parallel to myelinating cells since the apical compartment is enriched in specific 
glycosphingolipids, e.g. galactosylceramide and sulfatide which are also enriched in 
myelin (for review see Frank, 2000). MAL co-purifies with these glycosphingolipids in 
detergent insoluble complexes suggesting a role of MAL in subdomain formation of 
myelinating cells. Nevertheless, the situation in myelin structures is much more 
complex than simple apical vs. basolateral. Therefore, polarized sorting mechanisms 
from epithelial cells can provide general concepts but myelin specific protein sorting 
and trafficking probably needs much more elaborated systems. 
 
4.5 Cytoskeleton elements in myelinating cells 
Protein and lipid transport in all cells is dependant on cytoskeleton elements. Golgi 
derived vesicles travel along microtubule and microfilament tracks to reach their 
destination. There, they interact with specified target recognition systems and 
ultimately fuse. The role of cytoskeleton elements here is crucial and was to some 
extend studied in both Schwann cells and oligodendrocytes. 
 
4.5.1 Schwann cells 
Initially, Schwann cells polarize their plasma membrane into two domains the 
abaxonal and the adaxonal membrane. The abaxonal membrane is crucial for 
synthesis of the basal lamina (Bunge et al., 1986; Eldridge et al., 1987). The 
adaxonal compartment is enriched in MAG and in direct contact with the axon (Trapp 
et al., 1984). The polarization of Schwann cell membranes into distinct domains is 
dependant on cytoskeleton elements. Indeed, the transport of myelin proteins in 
Golgi-derived vesicles is dependant on microtubules (Trapp et al., 1995). The role of 
cytoskeleton elements, in particular microtubules (MTs) and microfilaments (MFs), 
has been studied in the mature myelin sheath. In myelinated internodes tubulin tracks 
emanate from perinuclear Golgi rich regions (Kidd et al., 1994). The majority of 
microtubules is polarized with their plus ends away from the perinuclear region and 
might serve as tracks for vesicular transport of myelin components. Still also minus 
end directed MTs are found with the implication that both minus and plus end 
directed transport might contribute to myelin formation in Schwann cells (Kidd et al., 
1994). The presence of the microfilament components f-actin and spectrin was 
shown in all non-compact myelin compartments where they co-localize with MAG 
Introduction 
   
30 
(Trapp et al., 1989). Additionally, an extensive intermediate filament (IF) network was 
found in the cytoplasmic compartments by immunoreactivity for vimentin (Trapp et al., 
1995). Still the role of the Schmidt-Lanterman incisures for protein and lipid turnover 
is not clear. Nevertheless, it is believed that non-compact myelin compartments and 
specially Schmidt-Lanterman incisures might be the hotspot where vesicle dependant 
turnover takes place. The microvilli and paranodal Schwann cell cytoskeleton is 
thought to be crucial for correct initiation and maintenance of the axonal nodal 
specialization. Still, in comparison to the cytoskeleton specialization of the nodal 
axolemma, the molecular makeup of the microvilli and paranodal cytoskeleton is still 
poorly understood. 
 
4.5.2 Oligodendrocytes 
Whereas Schwann cells only form one internode, oligodendrocytes extend multiple 
extensions to many internodes. Each internode has to be separately established and 
later on maintained. The respective myelin building blocks have to be transported and 
sorted through specific sorting mechanisms (for review see Pfeiffer et al., 1993). The 
primary and secondary processes of oligodendrocytes are filled with numerous 
organelles such as mitochondria and ER as revealed by EM (Barry et al., 1996). This 
arrangement of cellular organelles points to the local synthesis of myelin component 
in the processes (Barry et al., 1996). Still, they have to be correctly targeted and 
transported to integrate into the emerging myelin sheath. During myelination 
opposing myelin membrane layers become compacted leaving narrow cytoplasmic 
channels rich in microtubules. In culture, oligodendrocytes form flat membrane 
sheaths with comparable channels containing an extensive network of MTs and MFs 
but lacking IFs (Pfeiffer et al., 1993; Song et al., 2001; Wilson and Brophy, 1989). 
Vimentin as prominent IF is only present in OPCs but no longer expressed in mature 
oligodendrocytes (Barry et al., 1996). Microfilaments are present throughout the 
cytoplasm in the cell body and all processes. They are necessary in various 
processes to generate meshwork’s contributing to mechanical force and this is also 
true for oligodendrocytes (Simpson and Armstrong, 1999). Particular enrichment of 
MFs can be seen at the leading edges of processes and branching sites (Song et al., 
2001). The MT network is abundant in the cell body and all processes, but does not 
extend into the most distal tips of leading edges (Song et al., 2001). MTs in 
oligodendrocyte processes are thought to provide the tracks for directed vesicular 
and organelle transport. They are preferentially polarized with their plus end towards 
the cell periphery (Lunn et al., 1997). In nocodazole treated cells with disrupted MT 
network, the morphology and transport processes are disturbed (Carson et al., 1997; 
Lunn et al., 1997). Since oligodendrocytes can be cultured in vitro the identification 
and characterization of oligodendrocyte microtubule associated proteins (MAPs) was 
much more successful than for Schwann cells. In oligodendrocytes various MAPs in 
particular MAP2 and tau are expressed and developmentally regulated (Richter-
Landsberg and Gorath, 1999). Tau proteins are already expressed in OPCs and later 
on enriched at branching points and at the ends of mature oligodendrocytes 
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processes. Interestingly, oligodendrocytes switch the expression pattern of tau 
isoforms from splice variants with three MT binding domains to four towards 
maturation (Richter-Landsberg and Gorath, 1999). The different MAPs contribute to 
MT dynamics and stabilization to adjust the cytoskeleton during the different stages 
of differentiation and myelination. This might reflect the need for more stable MT 
tracks in more mature stages to stabilize the oligodendrocyte processes. 
 
4.6 The septins 
Septins are a family of cytoskeleton proteins which were identified in yeast as 
temperature sensitive mutants of cytokinesis (Hartwell, 1971). Septin mutants in 
yeast are demarcated by elongated mother-bud necks and multinucleated cells 
resulting from impaired septation. The phenotype was traced to four homologous 
genes CDC3, CDC10, CDC11 and CDC12 which were later termed septins. With the 
exception of plants, septins are well conserved throughout species (Pan et al., 2007). 
Interestingly, the number of isoforms and the complexity of splice variants increases 
tremendously from yeast to mammals. In humans, currently 14 septins are described 
showing multiple alternative splicing with tissue specificity of their expression (Hall et 
al., 2005). After the initial discovery in cytokinesis they where subsequently found in 
diverse tissues and additional functions of septins were soon discussed. Today, 
septins are thought to be involved in many cellular processes like cytokinesis, 
vesicular transport mechanisms and vesicle fusion as well as being important 
regulators of the other cytoskeleton systems, the microfilaments and microtubules 
(Kartmann and Roth, 2001; Kinoshita, 2003b). The presence of septins in myelinating 
cells has been demonstrated recently (Roth, 2006; Taylor et al., 2004). 
 
4.6.1 Septins in yeast 
Septin research in yeast looks back on four decades of investigation. After their 
discovery in 1971 as mutants of cytokinesis they were shown to localize to the 
mother-bud neck (Figure 10). S. cerevisae features an asymmetric division by 
polarized membrane growth at a distinct membrane location leading to the 
emergence of a bud. When the bud has reached the respective size and contains all 
subcellular elements as well as its nucleus, then, the daughter cell is separated from 
the mother cell by septation using an actomyosin contractile ring. During polarized 
bud growth, septins form a highly ordered filamentous structure known as the septin 
collar at the mother-bud junction (Byers and Goetsch, 1976; Kim et al., 1991). Septin 
mutants completely impair cytokinesis whereas disturbance of the contractile 
actomyosin ring only delays septation. This lead to the view that septins must act 
upstream of the later (Kim et al., 1991; Vallen et al., 2000). Septins were soon shown 
to interact abundantly among themselves. As mentioned, the S. cerevisiae septins 
co-localized at the mother-bud neck (Ford and Pringle, 1991; Haarer and Pringle, 
1987; Kim et al., 1991) and mutation of one septin isoform leads to the loss of the 
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others from the neck (Ford and Pringle, 1991; Haarer and Pringle, 1987; Kim et al., 
1991) suggesting that all yeast septins have to be present to form a functional 
complex. During the yeast cell cycle septins initially localize at the presumptive bud 
site as a ring structure. During polarized bud growth the septin ring expands to a 
collar at the mother bud neck (Figure 10). Coinciding with cytokinesis, the septin 
collar splits into two separate rings one of which will persist in each cell after division 
(Ford and Pringle, 1991; Kim et al., 1991). An interesting feature of septins is that 
they form a membrane bound barrier preventing the free diffusion of RNA and 
proteins between the emerging daughter cell and the mother cell (Takizawa et al., 
2000). Recently, it was shown that a septin dependant diffusion barrier also 
compartmentalizes the ER between the mother and the daughter cell (Luedeke et al., 
2005). None of the septins contains a transmembrane domain which implicates that 
septins interact with other membrane bound proteins or lipids. Besides organizing 
themselves, septins were also shown to localize specific elements required for 
septation like chitin synthase III to the mother-bud neck (DeMarini et al., 1997). 
Taken together, septins form a highly dynamic filament scaffold at the mother-bud 
neck organizing subsequent protein integration required for establishing a diffusion 
barrier and ultimately for the septation of the cells. 
 
 
 
 
Figure 10 The septin collar 
Electron micrograph of the emergind 
daughter cell in budding yeast. 
Septins form a filamentous ring 
structure at the mother bud neck (1a 
arrows). Septin mutants lack this 
septin collar (1b arrows) and cannot 
complete cytokinesis (copied from 
Byers and Goetsch, 1976). 
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4.6.2 Septin complex formation and structure 
Septins are cytoplasmic proteins of intermediate molecular weight between 30kD and 
75kD which display over 26% homology along the entire sequence (for review see 
Longtine et al., 1996). Overall septin domain structure can be divided in three regions 
(Figure 11). In a central region the homology is highest and this domain contains a P-
loop consensus sequence indicating a GTP binding cassette (Hall and Russell, 2004; 
Saraste et al., 1990). GTPase activity in vitro could only be attributed to some septins 
and the function of the GTPase motif is still unclear (Field et al., 1996; Frazier et al., 
1998). In contrast, the N-terminus is highly variable. The C-terminus implies predicted 
coiled-coil motifs for most septins but not all (Kartmann and Roth, 2001; Longtine et 
al., 1996). 
 
 
 
 
Figure 11 The septin protein domains 
Septin proteins contain a central GTPase domain with a G1, G3 and G4 cassette. The G1 cassette 
contains a P-loop motif responsible for nucleotide binding. The N-terminal domains are highly variable 
among different septins. The C-terminal regions contain predicted coiled-coil stretches for most but not 
all septins (copied from Field and Kellogg, 1999). 
 
 
The septin gene family comprises 2 isoforms in C.elegans, 3 isoforms in drosophila 
and 12 or more isoforms in mammals (Figure 12). For human septins it was reported 
that the septin transcripts undergo multiple alternative splicing potentially generating 
dozens of different polypeptides (Hall et al., 2005). To form higher order structures 
septins form heteromeric complexes with distinct stoechiometry. The prototype septin 
complex was isolated from Drosophila by immunoprecipitation and contained three 
septin isoforms in 1:1:1 relation (Field et al., 1996). Thereafter, the ultimate building 
blocks of septin structures were analyzed to be a tetramer for the nematode, a 
hexamer for mammalian and drosophila complexes and a octa- or decamer for fungal 
complexes (for review see Barral and Kinoshita, 2008). For mammalian complexes 
single isoforms are replaceable in the hexameric building block. This is due to higher 
complexity and redundancy among the septin family in mammals. Here, different 
combinations of septins are believed to fulfill different functions but still it is unclear 
how this might be achieved. Native and recombinant septin complexes can be 
purified and polymerized as 8nm thick filaments of variable length (Figure 13, Field et 
al., 1996; Frazier et al., 1998; Hsu et al., 1998). 
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Figure 12 The septin protein family 
The septin protein family can be grouped according to the sequence homology. Four subgroups are 
currently discussed (copied from Martinez and Ware, 2004). 
 
 
In mammals the septin family was grouped into four subgroups according to 
sequence homology (Figure 12, Kartmann and Roth, 2001). This classification so far 
parallels with the compatibility of the proteins to form recombinant complexes in 
insect cells (Kinoshita, 2003a). Seemingly, for a stable septin complex one member 
of each subgroup has to be integrated. In line with this, a septin complex model was 
proposed. In the fundamental SeptX/ 6/ 7 complex with a stoechiometry of 1:1:1 (X : 
1, 2, 4, 5), Sept6 is probably replaceable with Sept11, Sept8 and Sept10. Since being 
unique in terms of not having homologous isoforms, Sept7 might be crucial for all 
septin complexes. The role of Sept3, Sept9 and Sept12 in complex formation has to 
be further analyzed (Kinoshita, 2003a). Thereafter, other septins might be 
incorporated at sub-stoechiometric quantities. The in vivo composition of septin 
structures is still not well understood. 
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Figure 13 Septins form filaments in vitro 
Purified yeast septins form filaments in vitro as analyzed by electron microscopy. Depending on ionic 
strength variable filament lengths can be achieved (copied from Frazier et al., 1998). 
 
 
In vivo septin assemblies were originally discovered at the yeast mother-bud neck as 
10nm filaments circumfering the neck (Byers and Goetsch, 1976). The first 
ultrastructural data about septin filaments derived from EM studies. There, septin 
filaments appeared as consecutions of short filament segments with obscure polarity 
(Hsu et al., 1998; Kinoshita et al., 2002). These filaments can laterally assemble into 
higher order structures forming curved bundles, rings or coils. Rapid-freeze and 
deep-etch EM techniques showed that septins can also form ordered gauzes or 
scaffolds at the cell cortex (Rodal et al., 2005). Importantly, septins might use existing 
actin bundles as templates for assembly (Kinoshita et al., 2002). In vitro septin 
assembly is not coupled to robust nucleotide exchange or hydrolysis and the role of 
the GTP cassette in septin assembly and function is still matter of debate. In vivo, 
septins seem to rearrange abundantly probably controlled by diverse binding factors 
and covalent modifications. 
Comparable to the situation for actin, tubulin and intermediate filament proteins, 
crystallization of septins complexes was very challenging. Recently, the Wittinghofer 
group succeeded in crystallizing and reconstructing the human Sept2/ 6 /7 complex 
with atomic resolution (Figure 14). Surprisingly, they demonstrated that septins do not 
interact among themselves through their coiled-coil domains but rather the GTPase 
domains and stretches of their N-terminal domains (Sirajuddin et al., 2007). The 
coiled-coil domains were not visible in the crystal indicating that their orientation was 
flexible. The hexameric nature of the septin core unit was verified. Additionally, the 
polymerization of septins to filaments can be achieved by adding further hexamers in 
a linear fashion. Clearly, the septin filaments have no polarity which was also 
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concluded from other studies (John et al., 2007). According to the proposed model, 
septins might interact among themselves with the GTPase domains and with other 
proteins with the coiled-coil domain but the latter remains to be demonstrated. 
 
 
 
 
 
Figure 14 Ultrastructure of the human Sept2/ 6/ 7 complex 
The crystal structure of the human Sept2/ 6/ 7 complex has been solved. Importantly, septins interact 
via their GTPase domains. The coiled-coil domains (depicted as arrows) seem to be flexible and 
radiate laterally from the septin filament (copied from Sirajuddin et al., 2007). 
 
 
4.6.3 Septins in the mammalian central nervous system 
After the initial discovery in yeast septin homolog’s were soon found in higher animal 
species like Drosophila (Neufeld and Rubin, 1994) and ultimately in both mouse and 
human tissue (Nakatsuru et al., 1994; Nottenburg et al., 1990). A role in cytokinesis 
was demonstrated both for Drosophila and in mammalian cells (Kinoshita et al., 1997; 
Neufeld and Rubin, 1994; Surka et al., 2002). Since septins are also abundantly 
expressed in non-dividing tissues like the nervous system, additional functions 
besides cytokinesis are readily studied and described. Septins are thought to be 
important in cell polarity, cell cortex compartmentalization, vesicle transport and 
regulation of the actin and tubulin cytoskeleton and they also seem to be involved in 
numerous pathological conditions (Hall and Russell, 2004; Kartmann and Roth, 2001; 
Kinoshita, 2003b). In 1998, Hsu and colleagues identified a brain septin complex 
interacting with the exocyst or Sec6/8 complex (Hsu et al., 1998). The Sec6/8 
complex in yeast is crucial for directed vesicle integration into distinct plasma 
membrane regions. In neurons, the exocyst complex seems to display a comparable 
role targeting vesicles to specific sites during neurite outgrowth and synaptic 
assembly (Hazuka et al., 1999; Hsu et al., 1999). Further support for a role of septins 
in vesicle targeting derived from the fact that septins interact with the SNARE protein 
syntaxin (Beites et al., 1999). SNARE proteins are thought to be crucial for the 
thermodynamically unfavorable approach of two membrane bilayers necessary for 
mediating vesicle fusion. It is believed that distinct vesicle bound SNAREs interact 
with target SNAREs on the membrane and that this system might provide specificity 
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for vesicle targeting (Sollner et al., 1993). Importantly, Sept5 did not only bind to 
syntaxin but by that inhibited exocytosis. This suggests that septins might regulate 
the availability of free SNAREs for fusion of vesicles (Beites et al., 1999). Recently, 
Amin et al. demonstrated that the inhibitory function of Sept5 on syntaxin and thereby 
exocytosis is regulated by phosphorylation through Cdk5 (Amin et al., 2008). Taken 
together, these data suggest that septins may be important for vesicle targeting by 
interacting with the exocytosis machinery and by regulating the availability of free 
fusion sites in neurons. Besides regulating exocytosis septins may also be involved in 
regulating spine morphology. Sept7 was identified to localize to the bases of dendritic 
spines in mature hippocampal neurons (Xie et al., 2007). Importantly, neurons 
deficient for Sept7 displayed altered spine morphology. Additionally, alterations in 
Sept7 expression lead to changes in dendrite arborization (Tada et al., 2007; Xie et 
al., 2007). Besides having a presynaptic role in vesicle targeting septins might also 
exert a postsynaptic function since numerous septins were isolated from postsynaptic 
density fractions. Undoubtedly, septins might reveal new concepts for the highly 
polarized neurons and their extensive vesicular systems. Besides in neurons, septins 
may also have a role in astrocytes. Kinoshita and colleagues showed that Sept2 co-
localized with the glutamate transporter GLAST in Bergmann glia. Dominant negative 
mutants of Sept2 reduced the glutamate uptake via GLAST by internalization of the 
glutamate transporter (Kinoshita et al., 2004).  
 
4.6.4 Septins in oligodendrocytes and Schwann cells 
Very recently, it became evident that septins may also have a role in myelinating glia. 
Indeed, several proteomic screens for myelin and myelin-associated components 
revealed members of the septin family being incorporated into myelin fractions (Roth, 
2006; Taylor et al., 2004). Additionally, recent work on the null mutant of the main 
CNS myelin component proteolipid protein (PLP) revealed that distinct septin 
isoforms were lost in myelin of these mice (Werner et al., 2007). In humans, 
mutations in the Sept9 gene were associated with hereditary neuralgic amyotrophy, a 
recurrent painful brachial plexus neuropathy (Kuhlenbaumer et al., 2005). These data 
suggest a role for septins in myelinating cells. 
 
4.7 The contribution of cytoskeleton elements to subdomain formation in 
myelinating glial cells 
In most mammalian cells interaction of the cytoskeleton with the plasma membrane is 
involved in regulating shape and movement (Niggli and Burger, 1987; Stossel, 1982; 
Weber et al., 1999). The mediators between the membrane and cytoskeleton 
elements are diverse and range from signaling receptors to membrane lipids. It is 
well-known that myelin membranes are divided into subdomains with distinct protein 
and lipid composition. Nevertheless, it is unclear how these domains are generated 
and then maintained throughout the adult. Especially the mechanisms of interaction 
Introduction 
   
38 
between cytoskeleton elements and membrane structures in the developing and adult 
myelin sheath are not fully resolved. Data from several studies suggests that myelin 
components might interact with the cytoskeleton. Dyer and colleagues provided 
evidence that CNPase can directly interact with f-actin and MTs and that MBP 
domain organization might result from interaction with MTs (Dyer and Benjamins, 
1989a). Furthermore, they demonstrated that antibodies against galactocerebroside 
resulted in disruption of MT integrity and fusion of previously separated MBP domains 
(Dyer and Benjamins, 1989b). Wilson and Brophy showed interaction of CNPase and 
MBP with cytoskeleton fractions after detergent extraction (Wilson and Brophy, 
1989). This implies an intimate crosstalk between myelin and cytoskeleton elements 
crucial for proper structuring of myelin membrane domains. In line with this, 
oligodendrocytes derived from the shiverer mouse which lack most of the MBP 
expression display altered MT morphology in culture (Dyer et al., 1997). The precise 
cascade of proteins involved in the transduction of the interaction between the myelin 
components and the cytoskeleton remain unknown. Furthermore, the situation in 
mature internodes might be much more complex and involve more elements than 
during oligodendrocyte differentiation and initiation of myelination. Septins might be 
intriguing in this context since they abundantly interact both with the plasma 
membrane and the tubulin and actin cytoskeleton. In fact this interface between 
cytoskeleton elements and plasma membrane structures is unique and might be 
important to establish membrane subdomains (Barral et al., 2000; Martin and 
Konopka, 2004). The septin gene family gives rise to a complex set of different 
isoforms and transcript variants. The septin cortex of a cell can then form higher order 
structures like filaments and scaffolds by heteromeric assembly and interact focally 
with other cytoskeleton elements and membrane structures. The abundance of 
different building blocks opens up a myriad of levers for regulating the 
cytoskeleton/membrane interface of a given cell. In this respect, septins are intriguing 
mediators of cortex organization and might be crucial in the highly polarized 
myelinating cells the oligodendrocytes and Schwann cells. Many aspects of how 
these cells generate their distinct subdomains and organize complex membrane 
structures are not known. The study of septin function in myelinating cells might 
provide answers to these questions and help to understand the structuring of 
complex membrane systems. 
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5 Motivation and Aim of the Work 
 
Myelination is a uniquely complex and fascinating process. Oligodendrocytes and 
Schwann cells synthesize vast amounts of myelin membranes. They establish and 
maintain diverse subcompartments which are crucial for correct structuring of myelin 
internodes and functionality. Despite of decades of research, it is still not known how 
myelinating glia specifically transport and integrate myelin building blocks into the 
emerging myelin sheath. It is known that myelin membranes are divided into 
subdomains with distinct protein and lipid composition. How these domains are 
generated and maintained throughout the adult is currently heavily investigated. 
Cytoskeleton elements interacting with membrane components could generate and 
sustain such structural domains. Data from a yeast two hybrid screen suggested that 
the myelin and lymphocyte protein MAL may interact with septin 6 (Sept6) a member 
of a diverse cytoskeleton protein family, the septins. MAL is a mediator of 
compartmentalization in polarized cells and was already studied for its role in protein 
sorting and transport processes. In the myelin internode, MAL localizes both to the 
compact myelin compartment as well as non-compact compartments which is unique 
for myelin proteins. This suggests that MAL, indeed, might have a role in protein and 
lipid transport in myelinating cells. An interaction between MAL and the cytoskeleton, 
here the septins, opens up new concepts how myelin membrane domains are 
generated. Therefore, this work was aimed to verify and characterize the interaction 
between MAL and Sept6. Additionally, we aimed to analyze the septin gene family in 
myelinating cells. Not much was known about septins and their function in the 
nervous system, and no data on septins existed for oligodendrocytes and Schwann 
cells. Recent studies have only revealed the presence of septins in myelin but did not 
disclose their distribution and function. This work aimed to investigate the septin 
family in oligodendrocytes and Schwann cells with focus on their expression pattern, 
interaction with myelin structures and localization. Additionally, the downregulation of 
specific septin isoforms and the use of dominant negative septin mutants in 
myelinating DRG/ Schwann cell co-cultures to study septin function in vitro were 
planed. 
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6 Material and Methods 
6.1 Custom peptide antibodies 
Custom peptide antibodies against Sept2, Sept6 and Sept7 were generated. For 
each protein a peptide sequence from the N-terminus as well as one from the C-
terminus was chosen for immunization. 
 
6.1.1 Peptide sequences 
Sept2 N-terminal: MSKQQPTGFINPETP + C 
Sept2 C-terminal: C + QGGDSDSGALGQHV 
Sept6 N-terminal: AADIARQVGEDCRT 
Sept6 C-terminal: AGGSQTLKRDKEKKN + C 
Sept7 N-terminal: SVSARSAAAEERSVNC 
Sept7 C-terminal: C + EAQQRILEQQNSSRT 
 
6.1.2 Peptide synthesis and immunization 
Peptides were synthesized and used for immunization by Eurogentec, Belgium 
(DoubleXP protocol). 5mg of each peptide was coupled to hemocyanin. Two SPF 
rabbits for each protein were immunized with both peptides (4 injections: day 0, day 
14, day 28, day 56; 4 bleeds: day 0, day 38, day 66 and day 87). Generated antisera 
were purified using the respective peptide column as described below. Specificity of 
the antibodies was tested with Western blot analysis (chapter 6.1.4). 
 
6.1.3 Antibody purification 
The respective peptide column was washed with 10mM Tris pH7.5 until the detector 
signal was stable. 3ml of serum was diluted to 10ml with 10mM Tris pH7.5 and 
loaded thrice onto the column. Unbound proteins were cleared by washing the 
column with 10mM Tris pH7.5 until the detector signal was on baseline. The column 
was first washed with 6ml 500mM NaCl in 10mM Tris pH7.5 and further with 10mM 
Tris pH7.5. Specific antibodies were eluted by applying 100mM glycine-HCL pH 2.5. 
Ten 2ml fractions were collected and neutralized at once with 150μl 1M Tris-HCl pH 
8.0. Fractions with elevated OD280 absorption were collected and concentrated in 
Centricon dialysis units (Millipore, USA) and dialyzed 1:1000 to PBS. Protein 
concentration was determined by the Bradford method. 
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6.1.4 Western blot analysis with custom-made anti-septin antibodies 
The purified N- or C-terminus specific antibodies were characterized by Western blot 
analysis. 20μg myelin proteins were loaded on a 5-15% SDS-PAGE gradient gel. The 
Western blot analysis was performed as described in chapter 6.4. All septin 
antibodies were diluted 1:1000 and incubated with the membrane o.n. at 4°C. The N-
terminus specific septin antibodies revealed single bands at the calculated molecular 
weight of 41kD for Sept2, 49kD for Sept6 and 51kD for Sept7 (Figure 15). All C-
terminus specific antibodies did not generate specific bands. The N-terminus specific 
septin antibodies were, therefore, used for further applications. 
 
 
 
 
 
 
Figure 15 Myelin membranes were enriched by density gradient centrifugation. 20μg protein per lane 
was loaded on 5-15% SDS-PAGE gradient gels. The N-terminus specific as well as the C-terminus 
specific antibodies for Sept2, Sept6, Sept7 were used for Western blot analysis. The N-terminus 
specific antibodies generated single bands at expected molecular weight. 
 
6.2 Other antibodies 
The Sept4 antibody was purchased from Santa Cruz Biotechnology (sc-20179, USA). 
Sept8, Sept9 and Sept11 antibodies were kindly provided by Koh-Ichi Nagata 
(Institute for Developmental Research, Aichi, Japan). Monoclonal and polyclonal anti-
Caspr antibodies and anti-Gliomedin antibody were kindly provided by Elior Peles 
(The Weizmann Institute, Rehovot, Israel). The MBP antibody was purchased from 
Millipore (MAB386, USA). Anti-tubulin antibody was from Invitrogen (A11126, USA), 
and anti-beta-actin from Sigma (USA). Phalloidin-Alexa555 was purchased from 
Invitrogen (USA). Monoclonal anti-O1 and anti-O4 antibodies were kindly provided by 
Martin Schwab (Brain Research Center, University of Zurich, Switzerland). Polyclonal 
anti-MAL antibody was generated and characterized in the lab. 
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6.3 Yeast two-hybrid screen 
The yeast two-hybrid screen was performed using the yeast strain CG-1945 
harboring HIS3 and β-Gal as reporter genes (Fields and Song, 1989; Stegmuller et 
al., 2003). As bait, cDNA encoding the N-terminal cytoplasmic domain of MAL (amino 
acid 1-24, Schaeren-Wiemers et al., 1995) was subcloned into the pGBT9 vector 
(GAL4 DNA-binding domain vector, Clontech). Using the lithium acetate method, 
yeast was transformed sequentially with pGBT9-MAL and a postnatal (6 weeks) 
mouse brain MATCHMAKER cDNA library in pACT2 (GAL4 activation domain, 
Clontech). About 1 million transformants were screened. Transformants were grown 
on SD medium-Leu-Trp-His plates with 5mM 3-amino-1,2,4-triazole. Robustly 
growing colonies were tested for β-galactosidase gene activity: yeast were grown on 
SD-Leu-Trp-His, transferred onto reinforced nitrocellulose membrane (Schleicher and 
Schuell, Germany), submerged in liquid nitrogen, and placed on a Z-buffer/X-gal-
soaked Whatman (Z-buffer: 60mM Na2HPO4, 40mM NaH2PO4, 5mM KCl, 1mM 
MgSO4, pH 7; Z-buffer/X-gal solution: 100ml Z-buffer, 0.27ml β-mercaptoethanol, 
1.67ml 20mg/ml X-gal stock solution). Blue color was allowed to develop for 30’. DNA 
sequencing revealed two independent clones of Sept6 that both included the 
complete open reading frame. The specificity of the MAL-Sept6 interaction was 
confirmed by nutritional selection and β-galactosidase test of yeast co-transformed 
with pGBT9-MAL and isolated pACT2-Sept6, while pACT2-myc or isolated library 
plasmids served as negative controls. Unspecific interactions of pACT2-Sept6 were 
excluded by co-transformation of yeast with pGBT9 constructs expressing 
cytoplasmic domains of the unrelated transmembrane proteins PLP or GPM6B. 
 
6.4 Western blot analysis 
Appropriate amounts of protein were diluted in dilution buffer (33mM Tris pH6.8, 0.2% 
SDS) and incubated with 4x protein sample buffer (100mM Tris pH 6.8, 2% SDS, 
50% glycerol, bromphenolblue, 20% β-mercaptoethanol) for 1hr at 37°C. Proteins 
were separated on 5-20% SDS-PAGE gradient gels and transferred onto PVDF 
membranes at 50V for 1.5hr at RT. Unspecific binding sites were blocked with 3% 
Top-Block (Sigma, USA) for 2hrs at RT and incubated with primary antibodies o.n. at 
4°C. After four washes with TTBS (20mM Tris pH 7.5, 0.5mM NaCl, 0.1% Tween20) 
for 5’ at RT, membranes were incubated with fluorescent-coupled secondary 
antibodies for 1hr at RT. After four washes with TTBS and two with TBS for 5’ at RT, 
the membranes were scanned with the Odyssey system (LI-COR Biosciences, USA). 
The scan resolution was 84μm and the intensity was set to 5.0 for both channels. 
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6.5 Immunohistochemistry 
6.5.1 Teased peripheral nerve fibers 
Teased fibers were prepared as follows. The sciatic nerves of adult mice were 
prefixed 5’ in Zamboni fixation solution (2% PFA, 0.18% picric acid in Soerensen 
phosphate buffer pH 7.3) prior to removal from the animals. After excision, the sciatic 
nerves were further fixed in Zamboni solution for 10’ and washed twice for 15’ in PBS 
(PBS Instant Dulbecco, pH 7.4, Biochrom AG, Germany). After teasing, the fibers 
were dried on gelatin-chromalaun coated slides for 2hrs on a 37°C hot plate, and 
frozen at –20°C for storage. For immunohistochemistry, the teased fibers were 
permeabilized in acetone (-20°C) for 10’, and then washed in PBS (4°C) for 10’. 
Tissue samples were incubated for 1hr in blocking buffer (PBS, 1% glycine, 4% NGS, 
0.1% TritonX-100) and subsequently incubated with primary antibodies o.n. at 4°C. 
Afterwards, the fibers were washed in PBS at RT for 15’ and incubated with 
fluorochrome-coupled secondary antibodies for 30’ at RT. The teased fibers were 
washed for 15’ in PBS and 10’ in water before embedding in Fluorosafe (Calbiochem, 
Germany). 
 
6.5.2 Cryostat sections of fresh frozen human femoralis nerve tissue 
Cryostat sections of fresh frozen human femoralis nerves (10μm) were mounted on 
gelatin-chromalaun coated slides and fixed for 90’ with 10% buffered formalin 
solution. Delipidation was performed o.n. in 70% ethanol. Unspecific binding sites 
were blocked for 90’ at RT in blocking buffer (PBS, 1% glycine, 4% NGS, 0.1% 
TritonX-100). Primary antibodies were incubated at 4°C for 70hrs and fluorochrome-
coupled secondary antibodies 30’ at RT. Confocal fluorescent images were acquired 
on a Carl Zeiss LSM510 microscope. 
 
6.5.3 Cell cultures 
Cells were washed twice with ice cold PBS and fixed with 4% PFA in PBS for 15’ at 
RT. Following three washes with PBS for 5’, the cells were treated with methanol for 
15’ at –20°C. After two washes with PBS for 5’, the cells were incubated with blocking 
buffer (PBS, 5% BSA, 1% NGS, 0.2% TritonX-100) for 1hr at RT. The cells were 
incubated with primary antibodies o.n. at 4°C. The cells were washed three times with 
PBS for 15’ and incubated with fluorochrome-coupled secondary antibodies for 1hr at 
RT. Finally, the cells were washed three times with PBS for 15’, twice with water and 
embedded in Moviol. 
For the O1 (galactosylceramide) and O4 (sulfatide) epitopes, life stainings were 
performed as follows. If the cell culture medium did not contain 10% FBS unspecific 
binding sites were saturated with corresponding medium supplemented with 10% 
FBS for 30’ in the incubator prior to staining. The cells where incubated with undiluted 
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O1 or O4 supernatant for 30’ at RT, washed twice with PBS and then processed as 
described above for fixation and further staining. 
 
6.6 Electron microscopy 
The optic nerves of adult mice were fixed in Karnovsky solution (3% 
paraformaldehyde, 3% glutaraldehyde, 0.1M Cacodylatbuffer) at RT for 20’. 
Afterwards, the samples were postfixed with osmium tetroxide, dehydrated and 
embedded in EPON. Ultrathin sections of 70-80nm were contrasted by PB-Citrate 
and uranyl-acetat. Sections were imaged with a transmission electron microscope 
(Morgagni 268 D; FEI). 
 
6.7 Immobilization of IgG for Immunoprecipitation 
6.7.1 SeizeX ProteinA Immunoprezipitation kit (Pierce, USA) 
The coupling of IgG samples to proteinA sepharose was performed according to the 
manufacturer’s instructions. In short, 400μl proteinA sepharose was added to a filter 
tube and washed twice with binding/wash buffer (0.14M NaCl, 8mM sodium 
phosphate, 2mM potassium phosphate, 10mM KCl, pH 7.4). The purified antibody 
(100-150μg) was added to the sepharose and incubated 1hr at RT with end-over-end 
mixing. The beads were then washed thrice with binding/wash buffer. The filter was 
placed into a new collection tube and 400μl binding/wash buffer was added. A 
provided 2mg disuccinimidyl suberate (DSS) aliquot was dissolved with 80μl 
dimethylsulfoxide (DMSO). 25μl DSS in DMSO was supplemented to the bead 
suspension and incubated 1hr at RT on a rocker. The beads were washed five times 
with 500μl elution buffer (pH 2.8, contains primary amine), twice with binding/wash 
buffer and stored in binding/wash buffer with 0.1% sodium azide. 
 
6.7.2 ProFound Co-Immunoprecipitation kit (Pierce, USA) 
The coupling of IgG samples to aldehyde-activated beaded agarose was performed 
according to the manufacturer’s instructions. In short, 200μl AminoLink plus coupling 
gel 50% slurry were washed twice with coupling buffer (0.14M sodium chloride, 8mM 
sodium phosphate, 2mM potassium phosphate, 10mM KCl, pH 7.4). The antibody 
sample (600-700μg) was added to the beads. 3μl 5M sodium-cyanoborohydride 
(provided with the kit) was added to the slurry and incubated with end-over-end 
mixing for 4hrs at RT. The beads were washed twice with coupling buffer. Afterwards, 
400μl quenching buffer (1M Tris-HCl, pH 7.4) supplemented with 4μl 5M Na-
cyanoborohydride was added to the beads. The quenching reaction was incubated 
for 30’ at RT with end-over-end mixing. The beads were washed four times with wash 
solution (1M NaCl), twice with coupling buffer and stored in coupling buffer with 0.1% 
sodium azide. 
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6.7.3 Affi-Gel Hz Immunoaffinity kit (Biorad, USA) 
The coupling of IgG samples to hydrazide-agarose beads was performed according 
to the manufacturer’s instructions. Buffer exchange was performed as follows. The 
upper and bottom cap of Econo-Pac 10DG columns (provided in the kit) were 
removed and excess buffer on top was poured off. The columns were washed with 
20ml 1xHz coupling buffer and the antibody samples were applied to the columns. 
Then, 2ml 1xHz coupling buffer was added to the columns. 0.5ml elution fractions 
were collected and further 2ml 1xHz coupling buffer was applied while collecting 
fractions. The OD280 of collected fractions was measured and antibody containing 
fractions were pooled. Following this, the IgG samples were oxidized as follows. 
1.2ml water was added to one vial of sodium periodate (25mg, provided in the kit). 
3/10 volume sodium periodate stock solution was added to the IgG samples and the 
tubes were wrapped in aluminum foil to protect them from light. The samples were 
incubated with end-over-end mixing for 1hr at RT. The oxidation reaction was 
stopped by buffer exchange over Econo-Pac 10DG columns as described above. For 
coupling, 800μl Affi-Gel Hz gel was applied to a 5ml tube and allowed to settle. The 
supernatant was removed and the beads were washed twice with 2ml coupling 
buffer. 1ml coupling buffer was added and the beads were divided into two 2ml tubes. 
Oxidized IgG samples were added to the gel and rotated end-over-end for 24hrs at 
RT. The beads were washed once with 1ml 500mM NaCl in PBS, twice with 2ml PBS 
with 0.1% sodium azide and stored in PBS with 0.1% sodium azide. 
 
6.8 Immunoprecipitation 
6.8.1 Sample preparation 
All steps were carried out at 4°C if not otherwise stated. Sciatic nerves from 4 adult 
mice or rats were homogenized in lyses buffer (PBS, 2mM MgCl2, 0.5% DDTM 
(Anatrace, USA),   aprotinin, leupeptin, pepstatinA, PMSF) and incubated for 30’ with 
end-over-end mixing. Insoluble components were separated by centrifugation at 
18’000g for 30’. The supernatant was diluted 1:2 with PBS, 2mM MgCl2 and used for 
immunoprecipitation. 
For CNS myelin samples, myelin fractions were prepared as follows. The mice were 
decapitated and the brains transferred to 15ml tubes. 3ml solution A (250mM 
sucrose, 10mM HEPES, 2mM EGTA pH 7.4) containing protease inhibitors (aprotinin, 
leupeptin, pepstatinA, PMSF) was added to the tissue and the samples were 
homogenized with a polytron. 5.8ml solution C (2M sucrose, 10mM HEPES, 2mM 
EGTA pH 7.4) was added to obtain a 1.4M sucrose containing homogenate. These 
samples were mixed gently by inversion. A sucrose gradient was set up in Beckmann 
tubes (13x51mm) as follows. 1ml of solution C was added into the tubes and overlain 
by 8.5ml of homogenate. 2.2ml solution B (750mM sucrose, 10mM HEPES, 2mM 
EGTA pH 7.4) and 0.75ml solution A were added subsequently to the tubes. 
Afterwards, the tubes were centrifuged in a free swing out rotor type TST41.14 for 
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20hrs at 4°C and 25’000rpm (100’000g). The myelin membrane fractions were 
collected at the top of the gradient and transferred to new 15ml tubes. These samples 
were diluted with 10mM Hepes, 2mM EGTA pH 7.4 up to 13ml and centrifuged at 
100’000g at 4°C for 2hrs. The resulting myelin membrane pellet was resuspended in 
10mM Hepes, 2mM EGTA pH 7.4.  
For detergent extraction, 3 to 4.5mg of myelin proteins were incubated with an equal 
volume of extraction buffer (PBS, 2mM MgCl2, 2% DDTM, aprotinin, leupeptin, 
pepstatinA, PMSF) and homogenized with a syringe. The samples were then 
incubated for 30’ with end-over-end mixing before centrifugation at 18’000g for 30’. 
The supernatant was diluted 1:4 with PBS, 2mM MgCl2 and subjected to 
immunoprecipitation. 
 
6.8.2 Immunoprecipitation 
All steps were performed at 4°C in the cold room if not otherwise stated. Sepharose 
beads (20μl settled) with 40μg covalently coupled antibody were incubated with 
blocking buffer (3% BSA in PBS, 2mM MgCl2, 0.5% DDTM) for 15’ and washed once 
with washing buffer (PBS, 2mM MgCl2, 0.5% DDTM). Equal volumes of sciatic nerve 
or myelin detergent extract were incubated with sepharose beads with either anti-
septin antibody or control IgG for 4hrs with end-over-end mixing. Beads were washed 
three times with washing buffer for 10’. Bound proteins were eluted with elution buffer 
(100mM Tris pH 6.8, 0.6% SDS) at 37°C for 15’. The eluted proteins were separated 
on 5-20% SDS-PAGE gradient gels and either stained with the Colloidal Blue kit 
(Invitrogen, USA) or subjected to Western blot analysis. Protein bands were excised 
and subjected to tryptic digest. The masses of the resulting peptides were measured 
by electro spray ionization and matched to the Mascot database (Matrix Science Inc., 
USA, Paul Jenö, Mass Spectrometry Facility, Biocenter, University Basel). 
 
6.9 GST pull down assays 
6.9.1 Sept6 with MAL(1-55)-GST 
The MAL(1-55) N-terminal GST fusion construct or GSTTM1 was generated in the lab 
by Christoph Berger. Recombinant Sept6 was expressed in COS7 cells as follows. 
COS7 cells were transfected with the full length Sept6 sequence under the control of 
the CMV promoter (construct generated earlier in the lab, pcDSept6). Mock 
transfected cells were used as negative control. Plasmids were transfected with the 
Effectene transfection reagent (Qiagen, Germany). 1.2x106 cells were seeded on a 
100mm cell culture plate. The next day, 12μg DNA was diluted to 491μl with EC 
buffer. 96μl Enhancer was added and the mix was incubated for 5’ at RT. Afterwards, 
60μl Effectene was added and the transfection mix was incubated for 10’ at RT. 
Meanwhile, the cells were washed once with PBS (Sigma, USA). The transfection 
mix was diluted with 10ml DMEM (Sigma, USA), 10% FCS (Sigma, USA), Pen/Strep 
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(Sigma, USA) and added to the cells. After 24hrs the cells were washed with PBS 
and incubated with new medium for further 24hrs for protein expression. COS7 cells 
from one 100mm plate per pull down were trypsinized 5’ at 37°C. The trypsine 
reaction was stopped by addition of DMEM containing 10% FBS. After three washes 
with ice cold PBS the cells were resuspended in 100μl PBS containing protease 
inhibitors (aprotinin, leupeptin, pepstatinA, PMSF). Lyses was performed by addition 
of 100μl lyses buffer (PBS, 2mM MgCl2, 2% DDTM (Anatrace, USA), 2% OTG 
(Sigma, USA)) and the samples were incubated with end-over-end mixing for 30’ at 
4°C. The samples were centrifuged at 18’000g for 30’ to pellet insoluble material. The 
supernatant was diluted 1:2 with PBS, 2mM MgCl2 and subjected to the GST pull 
down. For the pull down assay, 20μl glutathione-sepharose 75% slurry was washed 
twice with PBS and incubated with 50μg GST or MAL(1-55)-GST protein for 1hr at 
RT. The beads were washed three times with PBS and once with cold washing buffer 
(PBS, 2mM MgCl2, 0.25% DDTM, 0.25% OTG) prior to incubation with samples. The 
COS7 cell extracts were incubated with loaded beads o.n. at 4°C. Afterwards, the 
beads were washed three times with washing buffer for 15’ at 4°C. Bound proteins 
were eluted with elution buffer (100mM Tris pH 6.8, 0.6% SDS) at 37°C for 15’ and 
analyzed with SDS-Page and Western blot analysis. 
 
6.9.2 Sept2/ 6/ 7 trimer with MAL(1-24)-GST 
6.9.2.1 Generation of the MAL(1-24)-GST construct 
The N-terminal 24 amino acid fragment of MAL was amplified with the following 
primer pair: 
 
5’HT-N-MAL:  5’-GATCCATGGCTCCGGCAGCGGCTTC-3’ 
3’HT-N-MAL:  5’-GATCCATGGAGTCAGGGAAGGTGGTGAAGACCGAGAAG-3’ 
 
The PCR reaction contained 38.5μl water, 5μl 10x buffer, 2μl dNTP (Promega, USA), 
1.5μl of each primer and 0.5μl Taq polymerase (Roche, Switzerland). The PCR 
program implied an annealing temperature of 70°C and 40 cycles. The PCR fragment 
was purified using the Qiagen Nucleotide Removal kit (Qiagen, Germany) and 
digested with NcoI (88μl sample, 10μl buffer D (Roche), 2μl NcoI (Roche), 37°C for 
4hrs). After digestion and purification with the Nucleotide Removal kit (Qiagen, 
Germany) the fragment was cloned in NcoI digested dephosphorylated pETGEXCT. 
The vector was prepared as follows. 10μg pETGEXCT vector was digested with NcoI 
as above and purified with the Qiagen PCR Purification kit (Qiagen, Germany). The 
purified digested vector was then dephosphorylated with shrimp alkaline 
phosphatase (30μl DNA, 50μl water, 10μl SAP buffer, 10μl SAP enzyme (Promega, 
USA), 37°C for 20’). Finally, the vector was purified with the PCR Purification kit. The 
ligation reaction was set up by mixing 7μl PCR fragment with 1μl vector, 1μl ligation 
buffer and 1μl T4 DNA ligase (Roche, Switzerland) and incubated at RT for 4hrs. The 
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ligation mix was used for transfection into DH5α by adding 2μl ligation mix to 50μl 
chemically competent bacteria. After incubation on ice for 30’, bacteria were heat 
shocked at 42°C for 1’ transferred on ice and supplemented with 250μl SOC medium. 
Ampicilline restistence was expressed for 1hr at 37°C prior to plating on agar plates. 
Colonies were screened with PCR with the 5’T7 and 3’HT-N-MAL primer (annealing 
temperature 54°C, 40 cycles). Positive clones were inoculated with 6ml LB medium 
containing ampicilline. Plasmids were prepared according to the Qiagen Mini Prep kit 
(Qiagen, Germany). The sequences were verified by sequencing (Microsynth, 
Switzerland) and one clone with correct sequence was chosen for protein synthesis. 
 
6.9.2.2 Expression and purification of recombinant GST fusion proteins 
One colony from a freshly prepared agar plate was inoculated with 20ml 2xYT 
medium supplemented with ampicilline (AppliChem, Germany) for both GST and N-
MAL-GST clones. This starter cultures were incubated o.n. at 37°C with shaking. The 
next morning 500ml 2xYT with ampicilline were inoculated 1:100 with starter culture. 
The cultures were grown for 2.5hrs with shaking until they reached an OD600 > 0.6. At 
this point the expression of recombinant fusion protein was induced by addition of 
1:500 100mM IPTG (AppliChem, Germany). The cultures were further incubated for 
6hrs with shaking. After this, the cultures were centrifuged at 4000g for 15’ and the 
pellets were frozen at –80°C until purification of the GST proteins. After thawing, each 
pellet was completely resuspended in 50ml B-PER solution (Pierce, USA) 
supplemented with one tablet Complete Protease Inhibitor Cocktail (Roche, 
Switzerland). The lyses of the bacteria was completed by incubation for 2hrs at RT 
with end-over-end mixing. Afterwards, the samples were centrifuged at 6000g for 30’ 
at 4°C. Meanwhile 2ml Glutathione-Sepharose 4B (Amersham, UK) was washed 
twice with 50ml PBS. The bacterial supernatant was added to the sepharose and 
incubated for 2hrs at RT with end-over-end mixing. The beads were washed thrice 
with 50ml PBS and subsequently transferred to disposable columns (Amersham 
Pharmacia Biotech Inc., USA) with 5ml PBS. Bound GST proteins were eluted with 
9ml 10mM glutathione in 50mM Tris pH 8.0. The samples were dialyzed twice 1:100 
to PBS and concentrated with Centricon filter units (Millipore, USA). Protein 
concentration was determined with the Bradford method. The protein samples were 
diluted to 0.5μg/μl with PBS and aliquoted to 100μl for use in the GST pull down. 
 
6.9.2.3 GST pull down assay 
Purified Sept2/ 6/ 7 trimer was kindly provided by Prof. Ian Macara (Center for Cell 
Signaling, University of Virginia, USA). 
20μl glutathione-sepharose 75% slurry was washed twice with PBS. 50μg of GST 
protein or MAL(1-24)-GST was added to the sepharose and incubated at RT for 1hr. 
The beads were washed once with PBS and the unspecific binding sites were 
blocked with blocking buffer (3% BSA in PBS, 2mM MgCl2, 0.5% DDTM (Anatrace, 
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USA), 0.5% OTG (Sigma, USA)) for 15’ at 4°C. Thereafter, the beads were washed 
once with washing buffer (PBS, 2mM MgCl2, 0.5% DDTM, 0.5% OTG) prior to 
incubation with septin trimer. The purified Sept2/ 6/ 7 trimer was diluted in washing 
buffer (125μg to 500μl) added to the loaded beads and incubated o.n. at 4°C. 
Afterwards, the beads were washed three times with washing buffer for 15’ at 4°C. 
Bound proteins were eluted by boiling in Laemmli buffer for 5’ and analyzed with 
SDS-PAGE and Western blot analysis. 
 
6.10 Light cycler quantitative real-time PCR 
6.10.1 Primer pairs for real-time PCR 
Primer pairs for Light cycler quantitative PCR were designed with the Clone Manager 
program (Table 1). Suitable primer pairs were chosen to overlap exon/intron junctions 
to avoid amplification of genomic DNA. Each primer alone and the PCR product were 
blasted using the NCBI blast server to exclude unspecific DNA amplification. 
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Primer name  Gene accession number Sequence     
5’Sept1   NM_017461.1   5’-TGCTGCCTCTACTTCATCTCAC-3’ 
3’Sept1       5’-ATCCCTCACCACTTCACAAGAC-3 
5’Sept2   NM_010891.1   5’-GTGCCTGTCATTGCGAAAGC-3’ 
3’Sept2       5’-GGTCTTGGGTCACTTCCTGTAG-3’ 
5’Sept3   NM_011889.1   5’-AACACTGGTCAACACCCTCTTC-3’ 
3’Sept3       5’-GCGTTTCTTCCTGGCAATGTTC-3’ 
5’Sept4   NM_011129.1   5’-ACTGCTGCCTGTACTTCATCTC-3’ 
3’Sept4       5’-TGCTTTCCTTTAGGGCTTGGTC-3’ 
5’Sept5   NM_213614.1   5’-TCAGACCTGGAGCCACAGAG-3’ 
3’Sept5       5’-TCGTAGCCCACTGGAATCGG-3’ 
5’Sept6   NM_019942.2   5’-TCCTACCATGACTCCCGAATCC-3’ 
3’Sept6       5’-CATTGATCTCGCTCACCGACTC-3’ 
5’Sept7   NM_009859.2   5’-GTACAGGTGGAGCAATCCAAAG-3’ 
3’Sept7       5’-GTTGGCATTCCTCTGGTGTAAG-3’ 
5’Sept8   NM_033144.1   5’-TGGGCGAAACTGGGATTGG-3’ 
3’Sept8       5’-GGTGGGCGTGATGAAGTAGAG-3’ 
5’Sept9   NM_017380.1   5’-ACTGCTGCCTCTACTTCATC-3’ 
3’Sept9       5’-TCTGCGTCCTCATCAAACTC-3’ 
5’Sept10  NM_001024911.1  5’-GGCGTCAGGTAGCAGCATTAG-3’ 
3’Sept10      5’-GGCAGCAGGAAAGTGACCAAG-3’ 
5’Sept11  NM_001009818.1  5’-CCAGCAAACCAAGAAGGACAAG-3’ 
3’Sept11      5’-AAGCGACATACAAGGGACAGAC-3’ 
5’Sept12  NM_027669.1   5’-TGACAAGTGCTGGGACCCTATC-3’ 
3’Sept12      5’-ATCCTGCTCCTGAAGGCATCTC-3’ 
5’Krox20  NM_010118.1   5’-TCTACCCGGTGGAAGACCTC-3’ 
3’Krox20      5’-CAGGGTACTGTGGGTCAATGG-3’ 
5’Oct6   NM_011141.1   5’-AGCCGCTGCTCAACAAGTG-3’ 
3’Oct6       5’-CTTCTCCAGTTGCAGGCTGTC-3’ 
5’MAL   NM_010762.4   5’-GTGAGACTTCCTGGATCACAC-3’ 
3’MAL       5’-CATGGACCACGTAGATCAGA-3’ 
5’MBP   NM_010777.3   5’-GGTCCAGGCTTCCTTTGTTTTCTT-3’ 
3’MBP       5’-TGTCCAGCGTGTTCTCCTAAGTCC-3’ 
5’CNP   NM_009923.1   5’-TGTGCCCACCCTTTCTTTTCC-3’ 
3’CNP       5’-CAATGACCCAGCCCTTTTATTACC-3’ 
5’P0   NM_008623.4   5’-CCTCTCAGGTCACGCTCTATG-3’ 
3’P0       5’-GCCCGCTAACCGCTATTTC-3’ 
5’40S   NM_029767.1   5’-CGTGAGGTTTGGAGGGTCAAG-3’ 
3’40S       5’-TGTGACGTTGGCGGATGAG-3’ 
5’60S   NM_009438.3   5’-GGAAGTACCAGGCAGTGACAG-3’ 
3’60S       5’-GCAGGCATGAGGCAAACAG-3’ 
 
 
Table 1 5’ and 3’ primers used for quantitative real-time PCR are displayed together with the 
respective gene accession number. The 60S and 40S genes were used for normalization and quality 
control. 
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6.10.2 Standard curve generation for real-time PCR 
PCR was performed on cDNA derived from P4 brain total RNA with respective primer 
pairs (see chapter 6.10.1). Specific PCR products were purified on TAE-gels and the 
bands were isolated with the Qiagen Gel Extraction kit (Qiagen, Germany). The PCR 
fragments were cloned into the pCR2.1-TOPO vector using the TOPO-TA Cloning kit 
(Invitrogen, USA) according to the manufacturer’s instructions. The sequences were 
verified by sequencing (Microsynth, Switzerland). For standard curve generation a 
dilution series with defined cDNA copy numbers was established. A standard curve 
was generated by fitting the crossing points of the 105, 104 and 103 copy number 
dilutions into a logarithmic regression. The copy number of a given gene in a mRNA 
pool was then determined by fitting the measured crossing point of the sample into 
the respective standard curve. 
 
6.10.3 Total RNA isolation from sciatic nerve tissue 
Total RNA from sciatic nerves was isolated with the RNA Lipid Tissue kit (Qiagen, 
Germany) according to the manufacturer’s instructions. Sciatic nerves from four 
C57Bl/6 mice per preparation were used for RNA extraction. The sciatic nerves were 
homogenized in 1ml Qiazol lyses reagent (Qiagen, USA) with a polytron. After 
homogenization, the samples were incubated at RT for 5’. Thereafter, 200μl 
chloroform was added and the tubes were shaken vigorously for 15’’. After 3’ at RT, 
the samples were centrifuged at 12’000g for 15’ at 4°C. The aqueous phase was 
further processed. One volume of 70% ethanol was added and the samples were 
loaded on Rneasy Mini Spin Columns (Qiagen, Germany). After centrifugation 
(13’000rpm, 15’’) the columns were washed once with the high salt buffer RW1 and 
twice with RPE (Qiagen, Germany) to remove remaining ions from the columns. The 
columns were centrifuged once empty in new collection tubes to get rid of the 
ethanol. Finally, the RNA was eluted twice with 30μl water. 
 
6.10.4 Total RNA isolation from cultured cells 
Total RNA from cultured cells was isolated with the RNA Micro kit (Qiagen, Germany) 
according to the manufacturer’s instructions. About 4x104 cells (one 60mm plate) 
were used for RNA extraction. Cells were scraped off with 350μl buffer RLT (RNA 
Micro kit, Qiagen, Germany) supplemented with β-mercaptoethanol. Afterwards, the 
cell suspension was homogenized with a polytron for 10’’. One volume of 70% 
ethanol was added and the samples were loaded on Rneasy Micro Spin Columns 
(Qiagen, Germany). After loading, the columns were washed twice with the high salt 
buffer RW1, once with buffer RPE and once with 80% ethanol to remove remaining 
ions. The columns were dried by centrifugation empty in new collection tubes for 5’ at 
max speed. The RNA was eluted with 14μl water. 
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6.10.5 Reverse transcription reaction 
1μg total RNA per sample was subjected to reverse transcription. 20μl reactions were 
set up as follows. RNA was either precipitated by ethanol or used directly depending 
on purity of the samples. The RNA samples were diluted to 11.5μl with water. 1μl of 
OligodT primer (Promega, USA) was added and the samples were incubated at 65°C 
for 5’ to resolve secondary RNA structures. The samples were then placed on ice. 
The reactions were supplemented with 4μl transcription RT buffer, 2μl dNTP mix 
(Promega, USA), 1μl Rnase inhibitor (Roche, Switzerland) and 0.5μl Transcriptor 
reverse transcriptase (Roche, Switzerland). The samples were incubated at 55°C for 
30’ for the RT reaction followed by 85°C for 5’ for inactivation of the RT enzyme. The 
cDNA was diluted 1:25 with 10mM Tris pH8.0 and used for the Light Cycler reaction. 
 
6.10.6 Quantitative real-time PCR 
2.5μl sample or standard was applied to a capillary (Roche, Switzerland). The PCR 
mix containing 0.5μl water, 0.5μl of each primer and 1μl SybrGreenII (Roche, 
Switzerland) was added to the capillaries. The capillaries were closed and 
centrifuged shortly at 4000rpm. The quantitative PCR program implemented 50 
cycles with an annealing temperature of 65°C. Determined mRNA copy numbers 
were normalized to the mRNA copy number of the 60S ribosomal protein subunit 
L13a. 
 
6.11 Cell culture 
6.11.1 Standard cell culture 
COS7 and NIH3T3 cells were cultured in DMEM (Sigma, USA), 10% FBS (Sigma, 
USA), Pen/Strep (Sigma, USA) on standard tissue culture plates and split 2-3 times 
per week 1:5 or 1:10 according to the cell density. 
 
6.11.2 Primary cell culture 
6.11.2.1 DRG/ Schwann cell co-cultures 
Dissociated mouse DRG/ Schwann cell co-cultures were generated basically as 
described earlier (Carenini et al., 1998). DRG’s were isolated from E13 embryos and 
dissociated by trypsinization with 0.25% trypsine solution (Sigma, USA) for 45’ at 
37°C. MEM containing 10% FBS was applied to stop the tryptic digest. The cells were 
separated by trituration through FBS coated fire polished Pasteur pipettes with four 
strokes and seeded on poly-L-lysine (Sigma, USA) and collagen (Cell Systems 
Biotechnologies, Germany) coated cover slips. One embryo was seeded onto eight 
12mm glass cover slips in 24 well plates (BD, Falcon). Cells were grown in MEM 
(Invitrogen, USA) supplemented with 0.4% glucose, 10% FBS (Sigma, USA) and 
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50ng/ml NGF (Sigma, USA). Myelination was induced four days after dissection by 
addition of 50μg/ml L-ascorbic acid (Sigma, USA). The medium was renewed every 
2-3 days. After 4 weeks in culture, myelination was observed in all wells. 
 
6.11.2.2 Primary oligodendrocytes from neurospheres 
Neurospheres were obtained from E13 mouse embryos according to the protocol 
provided by Prof. Wendy Macklin (Pedraza et al., 2008). The brain was dissected and 
the cerebellum removed. The tissue was homogenized by trituration with a 1000ml 
Gilson pipette tip with 25 strokes. Afterwards, the cell suspension was passed 
through a 70μm cell strainer (BD, USA). The cell suspensions from two brains were 
pooled and plated in T25 tissue culture flasks (BD, USA) without coating in 8ml 
DMEM/F12 (Invitrogen, USA) supplemented with L-glutamine (Sigma, USA), B27 
supplement (Invitrogen, USA) and 20ng/ml EGF (Sigma, USA). The resulting 
neurosphere cultures were passaged every 2-3 days at a ratio of 1:3. 
Oligodendrocyte precursor cells (OPCs) were obtained from passage two of the 
neurosphere cultures. The neurospheres were collected by centrifugation and 
resuspended in 5ml DMEM/F12, L-glutamine, B27, 20ng/ml FGF (Peprotech, USA), 
20ng/ml PDGF (Peprotech, USA). The cells were triturated with a blue 5ml 
disposable pipette (BD, USA) with 7 strokes and passed through a 70μm cell strainer. 
The cell suspension from one T25 tissue culture flask was seeded into one poly-D-
lysine (Sigma, USA) coated T75 tissue culture flask (BD, USA). After 4-7 days 
proliferating OPCs were abundant. For OPC isolation and enrichment, the T75 plates 
were shaken at 120rpm for 30’ at 37°C to remove dead cells and debris. The plates 
were further shaken at 200rpm for 6-8 hours to detach the OPCs from the surface. 
The OPC suspension was recovered and subjected to a differential adhesion assay 
to reduce the astrocytes in the cultures. The cell suspension was incubated on 
untreated Petri dishes for 30’ in the incubator. The astrocytes attached to the Petri 
dish surface and, therefore, their number was reduced in the final culture. The cell 
suspension containing the OPCs was recovered and the cells were counted for 
further experiments. For RNA isolation, 200’000 OPCs were seeded onto poly-L-
ornithine (Sigma, USA) coated 60mm cell culture plates (BD, USA) in 5ml 
DMEM/F12, L-glutamine, B27, 20ng/ml PDGF/FGF. Differentiated oligodendrocytes 
were obtained by switching the medium to SATO (Bottenstein and Sato, 1979) 
supplemented with 1% horse serum. 
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6.12 RNA interference 
ShRNA retrovirus constructs were made as follows. Reported effective target 
sequences for Sept2, Sept7 and MAG were subcloned into a modified pSRG 
retroviral system (provided by Ivo Spiegel, The Weizmann Institute, Rehovot, Israel). 
This construct expresses GFP for infection control under the control of the PGK 
promoter and the hairpin RNA sequence under the control of the H1 promoter 
(Brummelkamp et al., 2002a; Brummelkamp et al., 2002b). 
 
 
 
 
 
 
6.12.1 Target sequences 
Sept2: 5’-GAAUAUUGUGCCUGUCAUUG-3’ (Kinoshita et al., 2002) 
Sept7: 5’-AGAAAGCUAGCAGCAGUGAC-3’ (Kinoshita et al., 2002) 
MAG:  5’-CAUGGCGUCUGGUAUUUCA-3’ (Eshed et al., 2005) 
(The MAG construct was kindly provided by Ivo Spiegel, The Weizmann Institute, 
Rehovot, Israel) 
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6.12.2 Generation of retroviral RNAi constructs 
6.12.2.1 RNAi hairpin oligonucleotide sequences 
 
Sept2 sense primer (5’-3’): 
gatccccGAATATTGTGCCTGTCATTGttcaagagaCAATGACAGGCACAATATTCttttta 
 
Sept2 antisense primer (5’-3’): 
agcttaaaaaGAATATTGTGCCTGTCATTGtctcttgaaCAATGACAGGCACAATATTCggg 
 
Sept7 sense primer (5’-3’): 
gatccccAGAAAGCTAGCAGCAGTGACttcaagagaGTCACTGCTGCTAGCTTTCTttttta 
 
Sept7 antisense primer (5’-3’): 
AgcttaaaaaAGAAAGCTAGCAGCAGTGACtctcttgaaGTCACTGCTGCTAGCTTTCTggg 
 
6.12.2.2 Annealing of hairpin oligonucleotides 
The primers were purchased from Microsynth (Switzerland) and diluted to 3mg/ml in 
water. The annealing reaction contained 48μl annealing buffer (50mM Hepes, 
100mM NaCl pH 7.4) and 1μl of sense and antisense primers respectively. 
 
Annealing: 94°C, 5’ → 75°C, 10’ → 72°C, 10’ → 65°C, 10’ → 62°C, 10’ → RT 
 
6.12.2.3 Ligation and transformation 
The annealed hairpin sequences were cloned into HindIII/BglII digested pSuper 
vector. The plasmid was digested as follows. 10μg vector (30.8 μl), 57.2μl water, 10μl 
10x buffer B (Roche, Switzerland) was supplemented with 2μl HindIII (Roche, 
Switzerland) and incubated at 37°C for 1hr. Following this, 2μl BglII (Roche, 
Switzerland) was added to the reaction and the samples were incubated for further 
2hrs at 37°C. After the digestion the plasmid was purified with the Qiagen PCR 
Purification kit (Qiagen, Germany). The ligation reaction implemented 14.5μl water, 
0.5μl digested pSuper plasmid (HindIII/BglII), 2μl annealed oligonucleotides, 2μl 10x 
ligation buffer, 1μl T4 DNA ligase (Roche, Switzerland) and was incubated for 4hrs at 
16°C. After ligation 1μl BglII was added to each sample and the digestion was 
performed for 30’ at RT to decrease religation of digested vector (the BglII site is 
destroyed upon successful ligation). The constructs were transfected into DH5α by 
adding 2μl ligation mix to 50μl chemically competent bacteria. After incubation on ice 
for 30’, the bacteria were heat shocked at 42°C for 1’, transferred on ice and 
supplemented with 250μl SOC medium. Ampicilline resistance was expressed for 1hr 
at 37°C prior to plating on agar plates. Colonies were screened with PCR with the 
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5’T7 and 3’T3 primers (for PCR program see chapter 6.13.1). Positive clones were 
inoculated and plasmids were prepared according to the Qiagen Mini Prep kit 
(Qiagen, Germany). The sequences were verified by sequencing and one correct 
clone per construct was chosen for further use. 
 
6.12.2.4 Production of retroviral stocks 
Retroviral stocks were produced in the Helper virus-free Phoenix-Eco packaging cell 
line (as described by G. Nolan, Stanford, CA, USA) with calcium phosphate co-
precipitation transfection as follows. The cell culture medium for virus production was 
DMEM (Sigma, USA), 10% FBS (Sigma, USA), Pen/Strep (Sigma, USA). For virus 
production poly-L-ornithine (Sigma, USA) coated plates were used for better 
adherence of the cells. 5.5x106 cells were seeded per 100mm plate the afternoon 
prior to transfection. The next morning, 9ml new medium was applied to the cultures. 
All reagents were brought to RT before use. 28μg DNA was diluted to 1291μl with 
water. 208μl 2M CaCl2 was added to the DNA. 1.5ml 2xHBS pH 7.00 was added to a 
8ml tube. While vortexing slowly the DNA/CaCl2 solution was added drop wise to the 
2xHBS. Afterwards, the mixture was incubated for 15’ to allow Ca-phosphate 
precipitate formation. Meanwhile, 6μl 50mM chloroquine (Sigma, USA) was added 
per 100mm cell culture plate to neutralize the lysosomal pH. After the completion of 
precipitate formation the transfection mix was gently spread onto the cells. After 6hrs 
the cells were washed gently with PBS and 10ml new medium was applied. 48h after 
transfection the viral supernatant was recovered, centrifuged at 500g for 5’, aliquoted 
and snap frozen in liquid nitrogen. 
 
6.12.3 Retroviral infection 
Retroviral infection of cell cultures was performed as follows. One day after plating, 
undiluted viral stock was supplemented with 8μg/ml polybrene and left on the cells for 
2hrs. Afterwards, the viral supernatant was removed and the appropriate medium for 
further culturing was applied. For DRG/ Schwann cell co-cultures this procedure was 
repeated the second and third day after plating. 
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6.13 Generation of mCherry tagged Sept2 constructs 
6.13.1 Subcloning of the mCherry sequence into the retroviral pMX vector 
The DNA sequence for the red fluorescent protein mCherry was kindly provided by 
Prof. Tsien (UCSD, San Diego, USA). Primers to amplify the mCherry sequence were 
extended with the recognition sequences of the restriction endonucleases BamHI and 
NotI for cloning into the pMX retroviral backbone (kindly provided by Ivo Spiegel, The 
Weizmann Institute, Rehovot, Israel). Additionally, a HindIII recognition sequence 
was introduced in the 5’ primer for further cloning. The PCR reaction contained 
20.95μl water, 2.5μl 10x buffer, 0.5μl dNTP mix (Promega, USA), 0.5μl of each 
primer and 0.05μl Tag polymerase (Biolabs, USA). Following the PCR reaction the 
respective DNA band was isolated from a TAE gel, purified with the Gel Extraction kit 
(Qiagen, USA) and subjected to restriction digestion. 
 
5’ primer: 5’-GATGGATCCGACAAGCTTATGGTGAGCAAGGGCGAGGAG-3’ 
    BamHI           HindIII 
 
3’ primer: 5’-GATGCGGCCGCTTACTTGTACAGCTCGTCCATGCC-3 
          NotI 
 
PCR Program: 94°C, 56°C, 72°C → 94°C, 54°C, 72°C → 94°C, 52°C, 72°C → 72°C 
       5x        5x         20x 
 
The purified PCR fragment as well as the pMX vector were digested sequentially with 
BamHI (Roche, Switzerland) and NotI (Roche, Switzerland). The restriction reactions 
contained 10μl 10x restriction buffer, 2μl of enzyme, the DNA sample (purified PCR 
reaction or 10μg vector) and water up to 100μl and was incubated at 37°C for 4hrs. 
Following purification with the PCR Purification kit (Qiagen, USA) the digested 
mCherry DNA fragment was ligated into the digested pMX vector. The ligation 
reaction was set up by mixing 7μl mCherry fragment, with 1μl digested pMX vector, 
1μl 10x ligation buffer and 1μl T4 DNA ligase (Roche, Switzerland) and incubated at 
16°C for 4hrs. Thereafter, the construct was transfected into DH5α by adding 2μl 
ligation mix to 50μl chemically competent bacteria. After incubation on ice for 30’ the 
bacteria were heat shocked at 42°C for 1’, transferred on ice and supplemented with 
250μl SOC medium. Ampicilline resistance was expressed for 1hr at 37°C prior to 
plating on agar plates. Colonies were screened with PCR as described above. Single 
positive clones were inoculated with 6ml LB medium supplemented with ampicilline 
(AppliChem, Germany) and incubated o.n. at 37°C with shaking. Plasmids were 
isolated with the Qiagen Mini Prep kit (Qiagen, Germany) according to the 
manufacturer’s instructions. The DNA sequence was verified by sequencing 
(Microsynth, Switzerland) and one clone without mutation was chosen for further use.  
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The resulting pMX-mCherry vector could further be used to tag any protein N-
terminally or C-terminally using BamHI/HindIII or NotI/XhoI respectively. 
 
6.13.2 Subcloning Sept2 wild type into the pMX-mCherry vector 
The DNA sequence of Sept2 was amplified with primers extended with the 
recognition sequences of the restriction endonucleases BamHI and HindIII. The PCR 
reaction was performed as described in chapter 6.13.1. Afterwards the DNA band 
corresponding to the Sept2 sequence was isolated from a TAE gel and purified with 
the Gel Extraction kit (Qiagen, USA). The PCR product and the pMX-mCherry vector 
were digested with BamHI and HindIII. The restriction reaction contained 10μl 10x 
restriction buffer, 2μl of each enzyme, the DNA sample (purified PCR reaction or 
10μg vector) and water up to 100μl and was incubated at 37°C for 4hrs. After 
digestion, the DNA was purified with the PCR Purification kit (Qiagen, USA). The 
purified Sept2 fragment was ligated into the pMX-mCherry vector and transfected as 
described in chapter 6.13.1. One clone with the correct sequence was chosen for 
further use. 
 
5’ primer: 5’-GATGGATCCATGTCTAAGCAACAACCAACTCAG-3’ 
    BamHI 
 
3’ primer: 5’-GATAAGCTTGCCCACATGCTGCCCGAGAGC-3’ 
    HindIII 
 
6.13.3 Subcloning the S51N Sept2 mutant sequence into the pMX-mCherry vector 
The DNA sequence of the dominant negative Sept2 mutant S51N was kindly 
provided by Prof. Hsu Shu (Rutgers University, Piscataway, USA). The DNA 
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sequence of Sept2-S51N was amplified with primers extended with the recognition 
sequences of the restriction endonucleases BamHI and HindIII. The PCR reaction 
was performed as described in chapter 6.13.1. The DNA band corresponding to the 
Sept2-S51N sequence was isolated from a TAE gel and purified with the Gel 
Extraction kit (Qiagen, USA). The PCR product and the pMX-mCherry vector were 
digested with BamHI and HindIII. The restriction reaction contained 10μl 10x 
restriction buffer, 2μl of each enzyme, the DNA sample (purified PCR reaction or 
10μg vector) and water up to 100μl and was incubated at 37°C for 4hrs. Thereafter, 
the DNA samples were purified with the PCR Purification kit (Qiagen, USA). The 
purified Sept2 fragment was ligated into the pMX-mCherry vector and transfected as 
described in chapter 6.13.1. Unexpectedly, the sequencing of the pMX-S51N-
mCherry construct as well as the original construct from Prof. Shu revealed several 
additional mutations downstream of S51N. Therefore, these undesired mutations 
were eliminated as described in the following chapter. 
 
5’ primer: 5’-GATGGATCCATGTCTAAGCAACAACCAACTCAG-3’ 
    BamHI 
 
3’ primer: 5’-GATAAGCTTGCCCACATGCTGCCCGAGAGC-3’ 
    HindIII 
 
6.13.4 Mutation elimination in the pMX-S51N-mCherry construct 
A PfoI restriction site lies downstream of the S51N mutation (Figure 16). A second 
PfoI restriction site is located on the pMX-mCherry vector upstream of the multiple 
cloning site (not shown), and therefore, PfoI could be used to replace the DNA region 
containing the undesired mutations with the wild type sequence. However, the 
restriction analysis demonstrated that the PfoI restriction site downstream of the 
S51N mutation was not functional. PfoI allows all 4 bases on position 4 of its 
recognition sequence (TCCXGGA) according to the distributor (Fermentas, Canada). 
However, the sequence TCCTGGA (downstream of S51N) was not recognized by 
this enzyme whereas the sequence TCCGGGA on the pMX vector was efficiently 
recognized. Therefore, the PfoI sequence downstream of S51N was mutated to the 
functional sequence TCCGGGA by a PCR based mutagenesis strategy (Figure 16). 
This lead to a silent mutation at the respective base triplet in the Sept2 open reading 
frame. Two primer pairs binding at the PfoI site were designed. Two further primers 
were designed to bind at the 5’ end and the 3’ end of Sept2 respectively. The PCR 
reaction was performed as described in chapter 6.13.1. The PCR products were 
purified with the PCR Purification kit (Qiagen, USA). The purified fragment A was 
digested with PfoI and BamHI. The purified fragment B was digested with PfoI and 
HindIII. The pMX-mCherry vector was digested with BamHI and HindIII. The 
restriction reactions contained 10μl 10x restriction buffer, 2μl of enzymes, the DNA 
sample (purified PCR reaction or 10μg vector) and water up to 100μl and was 
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incubated at 37°C for 4hrs. All digested fragments were purified with the PCR 
Purification kit (Qiagen, USA). The fragments A and B were co-ligated into the 
digested pMX-S51N-mCherry vector by mixing 3.5μl fragment A, 3.5μl fragment B, 
1μl vector, 1μl 10x ligation buffer, 1μl T4 DNA ligase (Roche, Switzerland) and 
incubation for 4hrs at RT. The ligation was transfected into bacteria as described in 
chapter 6.13.1. Finally, the construct was sequenced to verify the correct sequence of 
the construct. 
 
 
 
Figure 16 Sequencing of the original Sept2-S51N sequence from Prof. Shu revealed besides the 
desired S51N mutation additional mutations (asterix). These unwanted mutations were eliminated by 
performing a PCR reaction with the primers P1 and P2 on the original Sept2-S51N sequence of Prof. 
Shu and with the primers P3 and P4 on the wild type Sept2 sequence. The resulting fragments A and 
B were co-ligated into the pMX-mCherry vector using the BamHI and HindIII restriction sites. 
 
P1: 5’-GATGGATCCATGTCTAAGCAACAACCAACTCAG-3’ 
   BamHI 
 
P2: 5’-GAGTCCCGGAATAATTCTTTCTGGGTAGAGAT-3’ 
       PfoI 
 
P3: 5’-GAGTCCGGGAGCTGCAGAGAAAATTGAAAGA-3’ 
       PfoI 
 
P4: 5’-GATAAGCTTGCCCACATGCTGCCCGAGAGC-3’ 
   HindIII 
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6.13.5 Production of retroviral stocks 
The retroviral supernatants were produced in the Helper virus-free Phoenix-Eco 
packaging cell line as described in chapter 6.12.2.4. 
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7 Results 
7.1 The cytoskeleton protein Sept6 interacts with the myelin protein MAL 
7.1.1 Sept6 is a potential interaction partner of MAL 
The myelin and lymphocyte protein (MAL) is a raft-associated proteolipid 
predominately expressed by myelinating glia. MAL is involved in apical sorting and 
transport mechanisms of polarized epithelial cells (for review see Frank, 2000). Its 
association with glycosphingolipids in myelin membranes suggests a role in the 
formation as well as the maintenance of myelin subcompartments. Additionally, MAL 
is necessary for correct localization of particular myelin components which are 
important for axon-glial interactions in the adult CNS (Schaeren-Wiemers et al., 
2004). Because polarized sorting and trafficking as well as subcompartment 
formation require cytoskeleton elements, we were interested in possible intracellular 
interaction partners of MAL. In collaboration with Hauke Werner (Department of 
Neurogenetics, Max-Planck-Institute of Experimental Medicine, Göttingen, Germany), 
a yeast two-hybrid screen with the intracellular N-terminal domain of MAL as bait with 
focus on cytoskeleton elements was performed. Septin 6 (Sept6), a member of the 
septin cytoskeleton protein family, was identified as a potential intracellular binding 
partner of MAL (Figure 17). 
 
 
 
 
 
Figure 17 The N-terminal intracellular domain of MAL was used to screen a cDNA library for brain 
specific interaction partners of MAL. The pGBT9 vector harbored the GAL4 DNA-binding domain and 
pACT2 the GAL4 activation domain. PLP and GPM6B (glycoprotein M6B) were used as negative 
controls since they display significant structural homology to MAL. HIS3 and β-GAL were used as 
reporter genes. Robustly growing colonies were tested for β-GAL activity. Only co-transfection of 
pGBT9-MAL and the isolated pACT2-Sept6 led to β-GAL positive colonies.  
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7.1.2 Verification of the Sept6 / MAL interaction by GST pull down 
The interaction between MAL and Sept6 was verified by a GST pull down assay. 
Sept6 was produced in COS7 cells and the cell lysate was subjected to GST-pull 
down. The DNA sequence of the N-terminal 55 amino acid fragment of MAL was 
fused to the sequence of glutathione-S-transferase (GST). GST alone was used as 
negative control. Recombinant proteins were expressed in E.coli and purified with 
glutathione-coupled sepharose. A defined amount of recombinant protein was loaded 
on glutathione-sepharose beads for the pull down assays. Sept6 was specifically co-
purified from a COS7 cells lysate with the N-terminal 55 amino acids fragment of MAL 
whereas GST alone did not (Figure 18). These data demonstrate that Sept6 binds to 
the N-terminus of MAL verifying the yeast two-hybrid screen. 
 
 
 
 
 
Figure 18 The Sept6 full length sequence under the control of the CMV promoter was transfected into 
COS7 cells. The cell lysate was used in a GST pull down assay. 50μg of recombinant GST-MAL or 
GST alone were loaded on glutathione-sepharose beads and probed for interaction against Sept6.  
 
7.1.3 The Sept2/ 6 / 7 complex does not interact with MAL 
Septins form heteromeric complexes which seem to be fundamental for septin protein 
stability and for function. We wanted to further characterize the interaction between 
MAL and septins by using a physiological brain septin complex (Sept2/ 6/ 7) 
expressed and purified from E.coli (kindly provided by Prof. Ian Macara, Center for 
Cell Signaling, University of Virginia, USA). The septin complex was incubated with a 
N-terminal 24 amino acids fragment of MAL fused to GST and then precipitated on 
glutathione-coupled sepharose. This fragment corresponds to the intracellular N-
terminal domain of MAL which was also used as bait for the yeast two hybrid screen. 
The Sept2 /6 / 7 complex could not be co-purified together with MAL (Figure 19). 
Different buffer conditions were used but did not lead to successful enrichment of the 
septin complex compared to the negative control. This is in contrast to the 
observation that Sept6 alone could be co-purified with MAL (Figure 18). A possible 
explanation is that the Sept6 domain which interacts with MAL is masked in the Sept2 
/6 /7 complex suggesting that Sept6 alone or a Sept6 complex of another composition 
might be responsible for interaction with MAL. 
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Figure 19 Purified Sept2/ 6 /7 protein complex samples were incubated with the N-terminal intracellular 
MAL fragment coupled to GST. GST alone was used as negative control. Different ionic strength 
([NaCl]) buffers were tested to optimize the pull down for specific protein interactions. No difference 
between the MAL-GST and the GST alone was evident.  
 
7.1.4 Sept6 and MAL are co-targeted to myelin fractions 
Sept6 was shown to interact with MAL in a yeast two-hybrid screen as well as in a 
GST pull down assay. Septins are cytoplasmic proteins which localize and interact 
with plasma membranes by interactions with proteins and lipids. MAL is 
predominantly localized to myelin fractions and we, therefore, asked if septins and in 
particular Sept6 are interacting with myelin membranes. For this, myelin membrane 
fractions were analyzed for co-purifying septins. Myelin membranes were enriched 
and separated from astrocytic and neuronal plasma membranes by density gradient 
centrifugation. Equal amounts of protein from crude homogenate, myelin membrane 
fraction and plasma membrane fraction were loaded on SDS-PAGE gradient gels and 
analyzed by Western blot. As expected the myelin protein MAL was targeted to the 
myelin membrane fraction (Figure 20). Sept6 was highly enriched in the myelin 
fraction suggesting interaction with the myelin membranes (Figure 20). Comparably, 
Sept2 and Sept7 were incorporated into the myelin membrane fraction suggesting 
that several components of the septin cytoskeleton might interact with myelin 
membranes. For Sept7, two protein bands could be detected one of which seems to 
be more prominent in myelin fractions. The two bands might correspond to 
differentially spliced isoforms since two splice isoforms were described for the human 
Sept7 gene (Nakatsuru et al., 1994). Both Sept7 splice isoforms were also detected 
in plasma membrane fractions. These data show that both MAL and Sept6 were 
highly enriched in myelin membranes. The interaction between the raft associated 
myelin protein MAL and the septin cytoskeleton opens up new concepts in the 
context of an interface between cytoskeleton elements and myelin subdomains. 
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Figure 20 The integration of septins and MAL into myelin membrane fractions was tested by Western 
blot analysis. Myelin membranes were separated from plasma membranes by density gradient 
centrifugation. 20μg of crude brain homogenate, myelin membrane fraction and plasma membrane 
fraction was loaded on SDS-PAGE gels. MAL was enriched in the myelin fraction as reported earlier. 
Accordingly, Sept2, 6 and 7 were co-purified with myelin membranes. 
 
7.2 The MALnull phenotype is not replicated in Sept6null mice 
MAL-deficient mice display structural alterations in paranode organization at the node 
of Ranvier. The paranodal loops, which are normally tightly connected to the axon, 
are detached from the nodal axolemma (Schaeren-Wiemers et al., 2004). This 
suggests that MAL is involved in the stabilization of the paranodal junctions. Although 
lack of MAL leads to reduced incorporation of particular paranodal components, it is 
not known how MAL contributes to the nodal architecture. Since we showed that MAL 
interacts with Sept6, we asked whether the paranodal alteration in MAL-deficient 
mice was due to an impairment of the septin cytoskeleton and further cytoskeleton 
elements. We, therefore, analyzed the Sept6null mouse (Ono et al., 2005) for changes 
in myelin ultrastructure (performed by Beat Erne, Neurobiology, Department of 
Biomedicine and Neurology, University Hospital Basel, Pharmacenter, Basel, 
Switzerland). Electron microscopy analysis revealed changes neither in the nodal 
architecture nor in other myelin compartments like the compact myelin and the 
Schmidt-Lanterman incisures. Notably, in Sept6 deficient mice the paranodal loops 
where tightly connected to the axolemma and no detached loops where found (Figure 
21). 
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Figure 21 The integrity of the paranodal organization in Sept6-deficient mice was analyzed by EM. The 
reported MALnull phenotype (2004 Schaeren-Wiemers et al.) characterized by detached paranodal 
loops (arrows) was not replicated in the Sept6null mouse. Bar 200nm. 
 
 
7.3 Sept11 compensates for loss of Sept6 in CNS myelin 
Next, myelin preparations of Sept6 deficient mice were analyzed for changes in 
protein composition. Neither the expression level of MAL nor of other myelin proteins 
analyzed (e.g. CNP, MBP, Neurofascin155) were altered (Figure 22). Septins are a 
complex family of proteins which display significant sequence homology to each 
other. It was already reported that homologous septins may compensate for the loss 
of single septins (Fujishima et al., 2007; Peng et al., 2002). To identify possible 
compensatory mechanisms, we performed Western blot analysis for several septins. 
Indeed, Sept11, the closest homolog to Sept6, was significantly elevated 1.6 fold in 
myelin membranes from Sept6-deficient mice (Figure 22). The closely related 
homolog Sept8 or Sept2 which belongs to a different septin subgroup (see also 
Figure 12) were not changed. Increased incorporation of Sept11 into myelin 
membranes as compensatory reaction to the loss of Sept6 clearly points to a 
functional role of Sept6 in myelin. 
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Figure 22 Sept6null myelin was analyzed for alteration in protein composition. Equal protein amounts of 
three independent myelin preparations per genotype were loaded on SDS-PAGE gels and subjected 
to Western blot analysis. The protein bands were quantified with the Odyssey Software (Licor, USA) 
and the respective signals were normalized to the wild type level. Sept11, the closest homolog to 
Sept6, was significantly elevated in Sept6null myelin (p<0.001). The protein levels of other septins were 
unchanged. 
 
7.4 Oligodendrocytes express and developmentally regulate a complex 
septin scaffold 
The analysis of Sept6null mice revealed that septin function in myelinating cells might 
involve many different isoforms. Data from several studies identified individual 
septins to be incorporated into myelin fractions (Roth, 2006; Taylor et al., 2004; 
Werner et al., 2007). Nevertheless, there were no comprehensive data about which 
septins are expressed in myelinating cells. Therefore, we analyzed the expression 
pattern of septins in primary oligodendrocyte cultures. Mouse primary 
oligodendrocytes were generated from neurospheres isolated from embryonic day 13 
cortical hemispheres with a protocol, which lead predominantly to the generation of 
oligodendrocyte precursors (Pedraza et al., 2008). The expression pattern of Sept1-
12 was analyzed in oligodendrocyte precursor cells (OPCs) as well as in 
oligodendrocytes, which were stimulated for differentiation for 4 and 7 days. The 
quality of the cultures was judged by analyzing several house keeping genes as well 
as particular myelin genes such as MBP, CNP and MAL (Figure 23A). CNP was 
induced immediately after stimulation, whereas MBP expression augmented with 
time. As known from earlier studies, MAL expression was induced much later than 
the other myelin genes. Ten different septins were expressed by oligodendrocytes all 
of which already to some extend were expressed in the OPCs (Figure 23B). Several 
septins, namely Sept3, 4, 5, 7, and 8 were strongly unregulated towards the MAL-
positive terminal differentiated stage, suggesting that they play a role in 
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oligodendrocyte differentiation and myelination. Especially, Sept4 showed an 
expression pattern reminiscent for a functional role in myelination since its expression 
was induced in a later phase of oligodendrocyte differentiation in a similar fashion as 
MAL. In contrast, Sept6 and Sept9 showed high expression already in OPCs and 
their expression levels were reduced to a steady state during the differentiation 
process. Still, their expression stayed high in differentiated oligodendrocytes, 
suggesting that those septins might play a role in OPC proliferation as well as in 
differentiation. Sept11, however, was transiently upregulated during the intermediate 
CNPase-positive stage and subsequently downregulated towards terminal 
differentiation, indicating a possible function during early differentiation of the 
progenitor cells. The absolute expression values of the septin gene family are 
depicted and compared to the expression pattern in sciatic nerve in Figure 25. Taken 
together, our data demonstrate that oligodendrocytes express a complex set of 
septins during all stages of differentiation.  
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Figure 23 Oligodendrocyte precursor cells (OPCs) were generated from neurospheres and 
differentiated to mature oligodendrocytes (4 days diff. / 7 days diff.). Total RNA was isolated from 
4x105 cells per sample. Four individual plates per time point were used and separately subjected to 
RNA isolation, cDNA synthesis and quantitative real time PCR. The expression of the indicated genes 
was measured with the Light Cycler system and normalized to the 60S house keeping gene. For 
depiction the time point of highest expression was set to one for each gene. (A) The expression of 
known myelin markers was monitored. The cells reached a CNPase/MBP positive intermediate stage 
after 4 days in differentiation medium. After 7 days, the oligodendrocytes also expressed late myelin 
markers like MAL. (B) The expression pattern of the septin gene family in oligodendrocytes was 
determined. A complex set of septins was expressed and developmentally regulated in the 
oligodendrocytes. 
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7.5 A distinct septin scaffold is upregulated during PNS myelination 
Oligodendrocytes and Schwann cells, besides being very different in regard of origin, 
are confronted with very similar tasks concerning membrane buildup and structuring. 
In line with this, both CNS and PNS internodes share basic structural features. 
Therefore, we also investigated the septin cytoskeleton in PNS myelination. Total 
RNA was isolated from sciatic nerves from postnatal day 0 (P0) to P28 to follow the 
developmental and myelination processes in the PNS. Schwann cell differentiation 
and myelination was monitored by the expression of Krox20 and Oct6 as markers for 
differentiation and P0, CNPase and MBP as markers for myelination (Figure 24A and 
B). In the sciatic nerve the expression of the same ten septins than in the 
oligodendrocytes was detectable (Figure 24C). Most of these septins were 
upregulated during the period of highest myelination activity around P14 – P21 and 
subsequently went down to a plateau. This pattern of expression clearly followed the 
expression pattern of the classic myelin proteins P0, CNPase and MBP (Figure 22A 
and B). Sept7 which is discussed as being crucial in most if not all septin complexes 
was already highly expressed around birth. Other septins like Sept3, 8, and 9 showed 
an upregulation of over 10fold coinciding with the peak of myelination. Sept4 in 
contrast was highly expressed at birth and was afterwards continuatively expressed 
at lower levels, indicating a role in Schwann cell proliferation. The absolute mRNA 
expression values are displayed in Figure 25. Interestingly, Sept7, 8 and 9 are highly 
expressed in both oligodendrocytes and Schwann cells. Sept4 seemed to be CNS 
specific whereas Sept3 was more abundant in the PNS. 
In summary, these data show that multiple septins are expressed and are 
differentially regulated in oligodendrocytes and Schwann cells many of those clearly 
parallel with myelinating activity.  
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Figure 24 Total RNA was isolated from sciatic nerves from postnatal day 0 (P0) to P28. The nerves of 
four animals per time point were pooled. Myelination was monitored by analyzing the expression level 
of several myelin genes as well as differentiation markers. The P28 time point was set to one for 
depiction. (A/B) As expected, classic myelin markers as well as Krox20, a marker for Schwann cell 
differentiation, showed a peak of expression in the period of highest myelinating activity (P14 - P21). 
(C) The expression of multiple septins was detectable. Notably, most expressed septins were 
upregulated during myelination. 
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Figure 25 The measured septin mRNA levels were normalized to the 60S gene. These absolute 
expression values are depicted for mature oligodendrocytes and myelinated sciatic nerves. For the 
oligodendrocytes, the septin expression pattern after 7 days in differentiation medium is displayed (A) 
and compared to the septin expression pattern of the postnatal day 28 sciatic nerve sample (B). 
 
Results 
   
73 
7.6 Discrete septin complexes interact with myelin membranes 
The expression analysis data showed that the septin cytoskeleton in myelinating cells 
is very complex. To identify septin scaffolds relevant for myelin membrane formation 
and maintenance, the composition of septin complexes incorporated into myelin 
fractions was analyzed by immunoprecipitation. Additionally, we wanted to directly 
verify the interaction of Sept6 and MAL in myelin fractions. 
 
7.6.1 Sample preparation for immunoprecipitation 
Myelin membrane fractions are difficult samples for immunoprecipitation since they 
are extremely hydrophobic. They cannot be directly used for pull down experiments 
due to their unspecific binding to sepharose beads. Therefore, mild detergents were 
used to solubilize myelin membranes without denaturing the proteins. After detergent 
extraction, the insoluble components were separated from soluble components by 
centrifugation. The supernatant was used for immunoprecipitation. Several 
detergents were tested for efficient solubilization of myelin proteins like MAL. Myelin 
membranes could be solubilized by using the detergent n-dodecyl-β-D-
thiomaltopyranoside (DDTM). Being non-ionic DDTM is considered to be a mild 
detergent preserving the protein tertiary structure and potentially also protein/protein 
interactions. The presence of septins as well as a selection of myelin proteins was 
tested in the soluble fraction after detergent extraction. Indeed, Sept2, 6 and 7 (not 
shown) as well as the myelin proteins MAL, MAG, Neurofascin, MBP and PLP were 
detected in the detergent extract (Figure 26). This myelin membrane extract was 
further used for all co-immunoprecipitation assays. 
 
 
 
 
 
Figure 26: A myelin membrane fraction was incubated with 1% DDTM for 30’. Subsequently, insoluble 
components were separated by centrifugation. The supernatant was analyzed by Western blot 
analysis. All tested septins and myelin proteins were detected in the detergent extract. 
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7.6.2 Co-immunoprecipitation for Sept6 using proteinA sepharose 
It was shown in this work that Sept6 interacts with the myelin protein MAL and is 
targeted to myelin fractions. As a next step, immunoprecipitation assays for Sept6 
were performed to isolate myelin-relevant septin complexes as well as co-purifying 
myelin components. The Sept6 N-terminus specific antibody was immobilized on 
sepharose beads. A standard method for antibody immobilization is to use proteinA 
sepharose. ProteinA specifically interacts with the Fc portion of IgG. Cross-linking 
agents can then be used to covalently attach the IgG to the proteinA sepharose. 
Indeed, the SeizeX ProteinA Immunoprezipitation kit (Pierce, USA) lead to efficient 
coupling of IgG. With this system, it was possible to immunoprecipitate Sept6 from 
solubilized myelin membrane samples (Figure 27). However, the background level of 
the negative control and even of the gel itself (not shown) was considerable. This 
might be due to the presence of the high amount of proteinA on the sepharose which, 
by itself, may be unfavorable to work with complex and highly hydrophobic samples 
as derived from myelin fractions. Therefore, this system was not further used. 
 
Figure 27 Sept6 specific antibodies were used 
to pull down septin complexes from solubilized 
myelin membranes. The elution fraction was 
analysed for Sept6 and Sept2 as well as MAL, 
Neurofascin (Nfc) and MAG. Sept6 could be 
purified from the myelin sample. However the 
background level on the control IgG beads was 
to high to specifically detect interaction partners 
of Sept6. 
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7.6.3 Co-immunoprecipitation for Sept6 using activated agarose 
Another method for antibody immobilization is to couple the IgG via primary amines 
on aldehyde-activated beaded agarose. This results in efficient but random coupling 
of the IgG directly on the agarose. The ProFound Co-Immunoprecipitation kit (Pierce, 
USA) led to efficient immobilization of IgG and low background signals in the negative 
control. Indeed, Sept6 could be purified from the solubilized myelin membrane 
sample (Figure 28). Together with Sept6, Sept2 specifically co-purified in the IP. The 
elution fraction was tested for interacting myelin components. Neither MAL nor any 
other tested myelin protein could be co-purified. No other protein band was evident 
from silver stained gels. A possible explanation might be that Sept6 was to low 
abundant in the myelin fraction. 
 
 
 
Figure 28 The ProFound activated sepharose 
system was used for co-immunoprecipitation 
assays. Solubilized myelin membranes were 
incubated with Sept6 or control IgG antibodies 
covalently coupled to sepharose. Sept6 was 
specifically enriched in the positive control. 
Sept2 co-purified with Sept6. 
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7.6.4 Co-immunoprecipitation for Sept2 
It was not possible to co-purify myelin components or further septins with antibodies 
against Sept6. This might be due to the relative low abundance of Sept6 in myelin 
membranes. Since we co-immunoprecipitated Sept2 together with Sept6 this septin 
was analyzed regarding myelin relevance. Septins are known to form heteromeric 
complexes important for their functionality. Therefore, we wanted to use Sept2 as a 
lever to isolate myelin specific complexes also regarding Sept6 and MAL. 
Immunofluorescence analysis of Sept2, revealed strong staining of all myelinated 
brain structures such as corpus callosum (Figure 29A arrow) and cerebellar white 
matter (Figure 29B arrowhead). For this reason, further co-immunoprecipitation 
experiments for this septin were performed (Figure 29B and C). Since it was 
recognized that the coupling with activated sepharose led to a reduced affinity of the 
antibodies, as reported in the literature, another oriented coupling technique without 
proteinA was used. The Affi-Gel Hz Immunoaffinity Kit (Biorad, USA) immobilizes IgG 
on sepharose via carbohydrate moieties on the Fc region of the antibodies, resulting 
in oriented coupling. This leads to efficient coupling and high antibody activity. 
Indeed, this system could be used to efficiently immunoprecipitate Sept2 with low 
background signal (Figure 29B). First, the interaction between Sept6 and Sept2 could 
be verified (Figure 32). Second, a distinct septin complex could be purified from 
myelin membranes. This septin complex was analyzed with SDS-PAGE both for CNS 
and PNS myelin membranes (Figure 29C). Visible bands after Coomassie staining 
(CBB) were excised and subjected to trypsine digestion and protein identification by 
mass spectrometry (Figure 30 and Figure 31). 
 
The presence of the identified Sept2 interactors was verified by Western blot analysis 
(Figure 32). From CNS myelin a distinct septin complex was co-precipitated together 
with Sept2. This complex contained besides Sept2 and Sept6 also Sept4, Sept7, 
Sept8, Sept9 and Sept11 (Figure 29C). The protein band intensities after silver 
staining implied that Sept2, Sept7 and Sept8 may represent a stoechiometric 
complex in CNS myelin. Interestingly, we were able to purify the same septin 
complex from a sciatic nerve homogenate with one major difference, the lack of 
Sept4. Sept2, Sept7 and Sept8 also represented a stoechiometric complex in the 
PNS (Figure 29C). Besides the septins, also actin was detected interacting with 
Sept2 and its complexes both in the CNS and PNS myelin fractions (Figure 29C, 30 
and 31). Tubulin was not pulled down together with this complex (data not shown). 
Besides septins and actin no further proteins co-precipitating with Sept2 could be 
detected suggesting that the interaction between septins and membrane components 
might be either destroyed upon detergent extraction or be to minor in respect to other 
complexes. 
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Figure 29 (A) Sept2 could be localized to myelinated fiber tracts (arrows) in the CNS by 
immunostaining. (B) Sept2 could be immunoprecipitated from myelin fractions both from the CNS and 
PNS. (C) Protein bands co-precipitating with Sept2 were isolated and identified by mass spectrometry 
(see also Figures 30 and 31). In CNS and PNS myelin Sept2/ 7/ 8 was the major stoechiometric septin 
complex. Besides this, Sept4, 6, 9 and 11 could be detected as minor components. Actin co-
precipitated with the septin complex both from CNS and PNS myelin. The presence of all identified 
septins was verified with Western blot analysis (Figure 32). No further membrane bound or soluble 
proteins could be co-precipitated. Bar 1mm 
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Identified: Sept8  P(pro): 4.15E-03 Score (XC): 28.17   
Peptides      Hits 
R.ISNAEPEPR.S       4 
K.VNIIPIIAK.A       1 
K.EFLSELQR.K         1 
 
Identified: Sept11  P(pro): 2.07E-08 Score (XC): 50.25   
Peptides      Hits 
K.AAAQLLQSQAQQSGAQQTK.K     4 
R.SYELQESNVR.L      2 
K.FESDPATHNEPGVR.L      2 
K.RNEFLGELQK.K      2 
K.STLM*DTLFNTK.F      1 
 
Identified: Sept7  P(pro): 1.07E-06 Score (XC): 40.15   
Peptides      Hits 
K.LKDSEAELQR.R      2 
K.FEDYLNAESR.V      1 
R.ILEQQNSSR.T       5 
K.DVTNNVHYENYR.S      1 
 
Identified: Actin  P(pro): 1.46E-07 Score (XC): 30.15   
Peptides      Hits 
R.GYSFTTTAER.E      2 
K.AGFAGDDAPR.A      2 
K.DSYVGDEAQSKR.G      2 
 
Identified: Sept2  P(pro): 3.72E-07 Score (XC): 54.22   
Peptides      Hits 
R.TVQIEASTVEIEER.G      2 
R.LTVVDTPGYGDAINSR.D     2 
R.M*QAQM*QM*QMQGGDTDSSTLGHHV.-   2 
K.ADTLTLKER.E       2 
K.ASIPFSVVGSNQLIEAK.G     1 
 
Identified: Sept9  P(pro): 4.31E-05 Score (XC): 28.13   
Peptides      Hits 
K.YLQEEVNINR.K      1 
K.VVNIVPVIAK.A      2 
K.ADTLTLEER.V       1 
 
 
Figure 30 Proteins co-precipitating with Sept2 from PNS myelin were identified. Visible bands after 
Coomassie blue staining were excised and subjected to tryptic digest. The masses of the resulting 
peptides were measured by electro spray ionization and matched to the Mascot database (Matrix 
Science Inc., USA). The protein probability P(pro) and the cross-correlation score XC are depicted. XC 
scores above 2.0 are indicative of a good correlation. 
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Identified: Sept8  P(pro): 4.56E-05 Score (XC): 58.15   
Peptides      Hits 
K.SLDLVTMK.K       4 
K.SLDLVTM*K.K       3 
R.VNMEDLR.E       2 
K.VNIIPIIAK.A       3 
K.VKETELELK.E       2 
K.EFLSELQR.K       1 
 
Identified: Sept11  P(pro): 8.14E-06 Score (XC): 30.14   
Peptides      Hits 
R.SYELQESNVR.L      2 
K.AAAQLLQSQAQQSGAQQTK.K    2 
 
Identified: Sept7  P(pro): 3.48E-08 Score (XC): 50.20   
Peptides      Hits 
R.QFEEEKANWEAQQR.I     2 
K.SPLAQMEEERR.E      2 
K.FEDYLNAESR.V      2 
K.DVTNNVHYENYR.S      2 
K.LAAVTYNGVDNNK.N      2 
 
Identified: Sept4  P(pro): 2.76E-0 4 Score (XC): 8.14   
Peptides      Hits 
R.VNIVPILAK.A       2 
 
Identified: Actin  P(pro): 6.78E-05 Score (XC): 18.17   
Peptides      Hits 
R.VAPDEHPILLTEAPLNPK.I     2 
R.SYELPDGQVITIGNER.F     1 
 
Identified: Sept2  P(pro): 4.90E-11 Score (XC): 116.29   
Peptides      Hits 
R.M*QAQM*QM*QMQGGDTDSSTLGHHV.-   26 
R.LTVVDTPGYGDAINSR.D     3 
R.YLHDESGLNR.R      2 
R.ILDEIEEHSIK.I       10 
K.VNIVPVIAK.A       2 
R.TVQIEASTVEIEER.G      1 
K.ADTLTLKER.E       2 
 
Identified: Sept9  P(pro): 5.97E-05 Score (XC): 40.15   
Peptides      Hits 
K.VVNIVPVIAK.A      2 
K.YLQEEVNINR.K      1 
K.STLINTLFK.S       2 
K.ADTLTLEER.V       2 
 
Figure 31 Proteins co-precipitating with Sept2 from CNS myelin were identified. Visible bands after 
CBB staining were excised and analyzed by mass spectroscopy. The protein probability P(pro) and the 
cross-correlation score XC are depicted. XC scores above 2.0 are indicative of a good correlation. 
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Figure 32 Septins co-precipitated together with Sept2 were identified by mass spectrometry (Figure 
29C, 30 and 31). Subsequently, their specific enrichment was verified. The elution fraction after 
immunoprecipitation was loaded on SDS-PAGE gels and analyzed by Western blot analysis. All 
identified septins were specifically co-precipitated together with Sept2. 
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7.6.5 A septin scaffold differentially interacts with myelin membranes 
In a next step, the distribution of the identified Sept2 interactors in myelin 
preparations from CNS samples was analyzed by Western blot. Similar to Sept2/ 6/ 7 
(Figure 20) also Sept4, Sept8, Sept9 and Sept11 were highly enriched in myelin 
fractions of the CNS (Figure 33A). For Sept8, three splice variants were identified in 
the brain homogenate (Figure 33A). Interestingly two of these Sept8 isoforms were 
enriched in the myelin membrane fraction, whereas one in the plasma membrane 
fraction, which predominantly consist of neuronal/axonal and astrocytic plasma 
membranes. To analyze if the identified septins also interact with PNS myelin 
fractions, myelin membranes were isolated from sciatic nerve homogenates and 
analyzed for co-purifying septins. Sept2, 7 and 8 all co-purified with the myelin 
fraction suggesting a specific interaction between these septins and the myelin 
membranes (Figure 33B). Here, the plasma membrane fraction could not be isolated 
due to the very high abundance of myelin membranes in the sciatic nerve 
homogenate as indicated by the major myelin protein P0. Sept6, 9 and 11 were not 
detectable by direct Western blot analysis. As illustrated by actin the specific 
interaction with myelin membranes is unique for septins (Figure 33B). 
 
 
 
Figure 33 The septins co-precipitating with Sept2 were analyzed for interaction with myelin 
membranes both from CNS and PNS. (A) In the CNS all analyzed septins were clearly enriched in the 
myelin fraction. Interestingly, three splice isoforms of Sept8 were detected two of which were 
specifically enriched with myelin fractions. (B) In the PNS the major septin complex Sept2/ 7/ 8 was 
detectable and interacted specifically with the myelin fraction. Sept6, 9 and 11 were not detectable by 
direct Western blot analysis. 
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7.7 The incorporation of septins into myelin is not dependant on MAL 
MAL is known to be involved in targeting specific elements to their respective domain. 
PLP and MAL are structurally related proteolipids but lead to different phenotypes in 
respective null mutants. A recent study of the PLPnull mouse demonstrated that the 
loss of the major myelin protein PLP results in a reduced incorporation of distinct 
septins into myelin fractions (Werner et al., 2007). We asked if the lack of MAL might 
result in a similar loss of septins from myelin membranes which might directly point to 
an interaction in vivo. Myelin preparations from MAL-deficient mice were analyzed for 
alterations in the level of septins by Western blot analysis (Figure 34). All tested 
septins such as Sept2, 4, 6, 7, 8, 9 and 11 were not altered suggesting that MAL is 
not crucial for localization of septins to myelin fractions or that the loss of MAL is 
compensated by PLP or other components of myelin.  
 
 
 
 
 
 
Figure 34 Myelin fractions from two MALwt mice and two mice MALnull were prepared as already 
described. Equal amounts of proteins were loaded on SDS-PAGE gels and used for Western blot 
analysis. MAL deficiency did not lead to alterations in the incorporation of septins into the myelin 
fraction. 
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7.8 Accumulation of septins in non-compact myelin structures 
Data from this work suggests that septins interact abundantly with myelin 
membranes. Still, the subcellular localization of septins in myelinated internodes was 
unknown. Therefore, a confocal co-localization study on teased fibers from sciatic 
nerves of adult mice was performed. Teased fibers from the PNS allow to reveal the 
precise localization of proteins in particular compartments of the myelin sheath. The 
subcellular distribution of the different septins was compared to the localization of 
Caspr, known to be specifically localized to the paranodal membrane of myelinated 
axons (Poliak and Peles, 2003), to MAG, which is detected in periaxonal membrane, 
paranodal loops and in Schmidt-Lantermann incisures (Erb et al., 2006), with 
Gliomedin, which is confined to microvilli (Eshed et al., 2005) and with actin localized 
in Cajal bands, Schmidt-Lanterman incisures and paranodal loops. Sept2 was 
detected in the Schwann cell cytoplasm of the Cajal bands (Figure 35A, arrow) where 
it co-localized with the actin cytoskeleton (Figure 35C, arrows). In addition, Sept2 was 
abundant in the paranodes and microvilli of the node of Ranvier (Figure 35A, asterix 
and Figure 35D, open arrow). Further, we identified co-localization of Sept2 with 
Caspr (Figure 35E, open arrows), suggesting that Sept2 may play a role in the 
paranodal loops. Besides this, Sept2 accumulations could be detected in the outer 
rim of the Schmidt-Lanterman incisures (Figure 35B, arrowheads), whereas in the 
cytoplasm of the incisures within the compact myelin sheath Sept2 could not be 
detected (Figure 35C, arrowheads). Furthermore, teased fibers were stained for all 
septins identified in the co-immunoprecipitation assays. Immunofluorescent analysis 
for Sept7, 8, 9 and 11 showed an equivalent accumulation in the microvilli at the 
nodes of Ranvier (Figure 35F asterix) and in Cajal bands (Figure 35F, arrows). 
Immunofluorescent analysis for Sept6 did not result in a specific signal in mouse 
sciatic nerve tissue. This might be due to the accessibility of the epitope or the affinity 
of the Sept6 antibody to undenatured Sept6. 
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Figure 35 Teased fiber preparations from sciatic nerves were stained for septins. (A) A cytoplasmic 
pool of Sept2 was detectable as Cajal bands (arrows). Besides this, Sept2 accumulated in the non-
compact myelin compartments, the Schmidt-Lanterman incisures (arrowheads) and at the nodes of 
Ranvier (asterix). (B) Sept2 co-localized with MAG at the outer rims of the Schmidt-Lanterman 
incisures (arrowheads). (C) The Cajal band localization was verified with co-localizing actin signal 
(arrows). (D/E) Sept2 highly accumulated in paranodal and microvilli regions where it co-localized with 
Gliomedin and Caspr (open arrows). (F) Besides Sept2, also Sept7, Sept8, Sept9 and Sept11 
accumulated at the nodes of Ranvier forming a complex septin scaffold (asterix). 
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7.9  Sept6 and MAL co-localize in the Schwann cell cytoplasm 
As mentioned, it was not possible to stain Sept6 in mouse teased fibers. Therefore, 
cross sections of human femoralis nerve tissues were stained to co-localize Sept6 
and MAL and determine the site of a possible interaction (performed by Beat Erne, 
Neurobiology, Department of Biomedicine and Neurology, University Hospital Basel, 
Pharmacenter, Basel, Switzerland). MAL was detected in the non-compact myelin 
compartment where it co-localized with MAG (Figure 36A, arrowhead) as well as in 
the compact myelin compartment co-localizing with MBP (Figure 36B, arrowhead). 
Additionally, MAL was detected in the Schwann cell perykaryon (Figure 36A and B, 
arrows). Sept6 was strongly detected in the perikaryon of the Schwann cells (Figure 
36C and D, arrow) but not in the non-compact (Figure 36C, arrowhead) and compact 
(Figure 36D, arrowhead) myelin compartments. These data indicate that interaction 
between Sept6 and MAL may take place in the cytoplasm of the Schwann cell. 
 
 
 
 
 
Figure 36 Human femoralis nerve autopsies were used for immunohistochemical co-localization of 
Sept6 and MAL. (A and B) MAL was detected in the compact (MBP+, arrowhead) and non-compact 
(MAG+, arrowhead) myelin compartments as reported earlier (Schaeren-Wiemers et al., 2004). In 
addition, MAL was detected in the Schwann cell perikaryon (arrows). (C and D) Sept6 signal was 
detected in the perikaryon where it co-localized with MAL (arrow). Additionally, Sept6 was found in the 
Cajal bands (open arrow). No Sept6 signal was detected in the abaxonal non-compact (MAG+, 
arrowhead) or compact (MBP+, arrowhead) myelin compartment. Bar 10μm 
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7.10 Disturbance of the septin cytoskeleton by RNA interference 
7.10.1 Myelinating DRG/ Schwann cell co-cultures 
Dorsal root ganglia (DRG)/ Schwann cell co-cultures are frequently used to study 
different aspects of Schwann cell biology. In this system, mechanisms like axon-glia 
interaction, myelination and myelin maintenance can be analyzed in vitro. Dorsal root 
ganglia from E13 mouse or E15 rat embryos are isolated and used for explant 
cultures. The cells are dissociated to obtain a single cell suspension of dorsal root 
neurons and Schwann cells. The neurons will generate extensive neurite trees. After 
the beginning of synapse formation some neurites will become myelinated by the 
Schwann cells (Figure 37). The first 2-3 days in culture, the Schwann cells are highly 
proliferative and can be infected by retroviruses. The retroviral vectors stably 
integrate into the Schwann cell genome and can be used to introduce constructs e.g. 
for RNA interference or expression of recombinant proteins. Then, the effect of the 
respective construct on myelination can be analyzed. We wanted to use this system 
to target the septin cytoskeleton of myelinating Schwann cells by RNA interference 
and analyze the impact on myelination. Therefore, myelinating DRG/ Schwann cell 
co-cultures were established. Published efficient RNA interference target sequences 
for Sept2 and Sept7 (Kinoshita et al., 2002) were from mouse and, therefore, mouse 
co-cultures were used in this study. A GFP reporter gene integrated in the retroviral 
vector was used to identify infected Schwann cells and selectively analyze the impact 
of the RNA interference construct on a single cell level. Myelinating DRG/ Schwann 
cell co-cultures were prepared as described earlier (Carenini et al., 1998). The 
medium was modified to increase myelination efficiency (according to personal 
communications Jonah Chan, Keck School of Medicine, Los Angeles, USA). Robustly 
myelinating cultures were obtained as judged by the formation of MBP+ internodes 
(Figure 37). These cultures were used to study the impact of septin loss on 
myelination. 
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Figure 37 Dorsal root ganglia (DRG) were isolated from E13 embryos and plated on cover slips after 
generation of a single cell suspension. The DRG neurons (Caspr+ cell bodies, asterix) generate a 
network of neurites (Neurofilament+ (NF), arrowhead) and the Schwann cells proliferate until they 
cover the cell culture area. After 4 weeks in culture, some Schwann cells begin to myelinate and form 
MBP+ internodes (arrows). Bar 100μm 
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7.10.2 Retroviral RNAi constructs targeting Sept2 and Sept7 
Reported effective RNAi target sequences for Sept2 and Sept7 (Kinoshita et al., 
2002) as well as the empty vector (GFP control) were used. The functionality of the 
retroviral construct was evident in fibroblast frequently found in the DRG/ Schwann 
cell co-cultures which also expressed both Sept2 and Sept7 (Figure 38). Respective 
cultures and control cultures were stained for Sept2 or Sept7. Sept2 or Sept7 were 
specifically lost after targeting with the respective RNAi constructs (Figure 38B and 
D). The GFP negative control did not affect the levels of Sept2 or Sept7. In 
conclusion, the target sequences efficiently downregulate Sept2 and Sept7, 
respectively, as reported earlier (Kinoshita et al., 2002). 
 
 
 
Figure 38 Infected fibroblasts were 
used to qualify the RNAi constructs 
(Kinoshita et al., 2002). In control 
infected fibroblasts (GFP control) the 
septin signal was indistinguishable 
from non-infected cells (A and C). 
The Sept2 and Sept7 RNAi 
constructs lead to a profound loss of 
Sept2 and Sept7 signal respectively 
(B and D). Bar 50μm 
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7.10.3 Control infected co-cultures myelinate normally 
The established myelinating DRG/ Schwann cell co-cultures were infected with 
retroviral particles at day 1, 2 and 3 after plating. As a negative control for further 
experiments a reported construct downregulating MAG with no effect on myelination 
was analyzed. This construct lead to successful infection of Schwann cells (Figure 
39, GFP+) which formed intact internodes of myelin (Figure 39, arrow) in a very same 
fashion as reported earlier (Carenini et al., 1998; Eshed et al., 2005). These data 
indicate that infection and the activation of the RISC complex upon RNA interference 
per se did not disturb normal myelination in this co-culture system.  
 
 
 
 
 
Figure 39 Myelinating DRG/ Schwann cell co-cultures were infected with a retroviral construct 
expressing a RNA hairpin targeting MAG. GFP was expressed under the control of a second promoter 
and was used as infection control. Schwann cells were infected with varying frequencies depending on 
the initial density of the culture. Ideally, the infection efficiency was up to 30% but frequently 10-20% of 
the Schwann cells were infected. The cultures were analyzed for GFP+ cells which formed MBP+ 
internodes (arrow). The downregulation of MAG did not impair normal myelination indicated by MBP 
expression and Caspr clusters. 
Results 
   
90 
7.10.4 Downregulation of Sept2 has no impact on myelination 
The myelinating DRG/ Schwann cell co-cultures were infected with retroviral 
supernatants targeting Sept2. The infected Schwann cells were analyzed for myelin 
formation indicated by MBP and nodal integrity by the paranodal marker Caspr. 
Schwann cells were infected in a similar frequency than control MAG RNAi-infected 
cells (Figure 40A and B). Most important, they were able to form normal MBP-positive 
internodes with Caspr clusters (Figure 40E) indicating normal formation of the nodal 
and paranodal structures in absence of Sept2. These data indicate that 
downregulation of Sept2 in Schwann cells does not have an effect on myelination 
efficiency or internode integrity. 
 
7.10.5 Downregulation of Sept7 may impair Schwann cell survival 
In contrast, DRG/ Schwann cell co-cultures subjected to RNA interference for Sept7 
lead not to comparable numbers of infected Schwann cells in five independent 
experiments (Figure 40C). After induction of myelination only few GFP-positive cells 
remained, probably correlating to the penetrance (infected, but not active) of the 
construct. As early as two days after infection, the number of GFP-positive cells was 
very low. These data suggest that loss of Sept7 may have an impact on Schwann cell 
survival. However, it was not possible to quantify this effect since it was not possible 
to pin down an early time point where the cells robustly expressed GFP as marker for 
infection but were still viable. In conclusion, Sept7 may have essential functions for 
Schwann cell biology and loss of Sept7 leads to death of the cells already during 
early differentiation stages. These cultures, therefore, cannot be used to study the 
function of Sept7 in myelination.  
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Figure 40 Myelinating DRG/ Schwann cell co-cultures were infected with retroviral particles bearing 
constructs downregulating Sept2 or Sept7. A RNAi construct targeting the myelin protein MAG was 
used as negative control. (A-C) Cultures were infected at day 1,2 and 3 after dissection. After 
myelination comparable numbers of infected Schwann cells (GFP+) were found for MAG RNAi and 
Sept2 RNAi. In contrast, only few cells were positive for the Sept7 RNAi construct and myelination 
could not be qualified. (D) Schwann cells downregulating MAG were able to form normal MBP+ 
internodes and Caspr clusters (arrowheads) as reported elsewhere. (E) Comparably, loss of Sept2 had 
no impact on myelination. Bars: A-C: 60μm; D-E: 32μm 
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7.11 A dominant negative approach to disturb the septin cytoskeleton 
Several dominant negative mutants of Sept2 were described in the literature (Schmidt 
and Nichols, 2004; Vega and Hsu, 2003). The S51N mutation of Sept2 impaired the 
GTPase activity and led to aberrant neurite sprouting in PC12 cells (Vega and Hsu, 
2003). Here, the effect of the dominant negative Sept2 mutation S51N on myelination 
was analyzed. The wild type Sept2 as well as the S51N mutant Sept2 sequences 
were fused C-terminally to the sequence of the red fluorescent protein mCherry 
(kindly provided by Prof. Tsien, UCSD, La Jolla, USA) as indicator of infection and for 
recombinant protein localization. The mCherry sequence as well as the respective 
Sept2 sequences were subcloned into the pMX retroviral vector. Accordingly to the 
RNAi constructs, the pMX constructs were packaged into retroviral particles. The 
retroviral supernatants were used to infect DRG/ Schwann cell co-cultures. The 
subcellular distribution of wild type Sept2-mCherry was analyzed in fibroblasts 
present in the co-cultures. These cells have a flat morphology and, therefore, the 
visualization of cytoskeleton components is straightforward. Infected cells displayed 
filamentous Sept2-mCherry structures (Figure 41). In addition punctuated signal was 
detected throughout the whole cell cytoplasm. This staining pattern is indicative for 
normal Sept2 distribution since Sept2 was reported to interact with actin bundles in 
cultured cells (Kinoshita et al., 2002). Most important, we could not detect aggregates 
of Sept2-mCherry. These data demonstrate that C-terminally tagged Sept2 
distributes like wild type Sept2 and does not lead to impaired septin structures in 
cultured cell. 
 
 
 
 
 
Figure 41 Cultured fibroblasts were infected with a retroviral construct expressing tagged Sept2. The 
red fluorescent protein mCherry was C-terminally fused to Sept2. Infected cells displayed normal 
morphology and Sept2-mCherry distribution. Bar 20μm 
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The DRG/ Schwann cell co-cultures were analyzed for mCherry positive myelinated 
internodes. The internodes expressing wild type Sept2-mCherry showed comparable 
Sept2 protein distribution as endogenous Sept2 stained by immunohistochemistry 
(Figure 42). These data show that Sept2-mCherry distributes similar to wild type 
Sept2 and, therefore, this construct could be further used to study septin dynamics by 
live imaging. However, the number of internodes positive for wild type Sept2-mCherry 
was low. Additionally, the mCherry signal was weak, which lead to difficulties to 
separate it from the background. A possible explanation might be that the retroviral 
promoter used in this construct was only weakly activated in Schwann cells. 
 
 
 
 
Figure 42 DRG/ Schwann cell co-cultures were infected with retroviral particles bearing the Sept2-
mCherry construct. After myelination, the cultures were analyzed for mCherry positive internodes. (A) 
The Schwann cells expressing the Sept2-mCherry construct were able to form normal MBP+ 
internodes. Sept2-mCherry distributed along the entire length of the internode. At the nodes of Ranvier 
Sept2-mCherry accumulations co-localizing with Caspr clusters were detected. Along the internode the 
Sept2-mCherry signal concentrated in the tubular channels of the Cajal bands (arrowheads). (B) 
Immunohistological staining of endogenous Sept2 showed comparable localization as for the Sept2-
mCherry. Bar 20μm 
 
 
The DRG/ Schwann cell co-cultures infected with the S51N Sept2 mutant were 
analyzed for myelinated internodes positive for mCherry. No myelinated internode 
expressing the dominant negative Sept2 mutant was ever found. This might be due to 
vital effects on the Schwann cells as observed for the Sept7 RNA interference. Yet, it 
was not possible to quantify this effect since the number of internodes expressing the 
Sept2-mCherry negative control was already too low. 
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8 Discussion 
 
Schwann cells and oligodendrocytes are the myelin forming cells in the PNS and 
CNS respectively. During myelination they establish and maintain an extensive 
membrane system with discrete domains. How compartmentalization of the myelin 
membranes is achieved and maintained is still not understood, yet it is clear that the 
integrity and function of the myelin sheath is critically dependant on correct 
structuring. Septins were described in many systems as membrane organizing 
proteins with important roles in processes like cytokinesis, protein transport and 
exocytosis (Kartmann and Roth, 2001; Kinoshita, 2003b). Septins have a crucial role 
in the organization of the cytoskeleton since they were shown to influence the actin 
and tubulin network under different conditions and to provide a link between these 
filament systems and the plasma membrane (Kinoshita et al., 2002; Kremer et al., 
2005; Peng et al., 2002). Therefore, septins are interesting in the context of myelin 
membrane formation and compartmentalization. Recently, several studies pointed to 
the presence of septins in myelin membranes (Roth, 2006; Taylor et al., 2004; 
Werner et al., 2007), but their functional role in myelination is unknown. In this study, 
we show that septins are intriguing candidates for subcompartment formation and 
cytoskeleton regulation during myelination and maintenance. 
 
We became interested in the septin protein family by identifying Sept6 as a binding 
partner of the myelin protein MAL. Sept6 interaction with the N-terminus of MAL was 
demonstrated in two independent experimental systems, however was not achieved 
with a Sept2/ 6 /7 complex. This is of interest because it suggests that the binding of 
septins to non-septin binding partners, here MAL, might be dependant on the 
composition of the septin heteromeric unit. Septin structures in vivo are complex and 
integrate many different isoforms in stoechiometric and non-stoechiometric ratios 
(Kinoshita, 2003a; Kinoshita et al., 2002). Septin scaffolds might, therefore, interact 
with binding partners in dependence of their composition. To follow this up, it would 
be necessary to test purified septin complexes of different composition for interaction 
with MAL. A parallel analysis of interactions of septin complexes with PLP might shed 
light on the question why distinct septins are lost in PLPnull myelin whereas others, 
like Sept7, are unchanged (Werner et al., 2007). Differences of septin interaction with 
PLP and MAL regarding complex composition would open up new concepts how 
septin scaffolds could focally interact with different membrane structures. Up to day, 
only few septin interaction partners have been described in mammalian systems 
(Table 2). In fact, despite of their abundant interaction with membranes, MAL is one 
of the first transmembrane proteins shown to interact with septins. Indeed, the myelin 
sheath might be a promising model system in which to study how septins contribute 
to compartmentalization of membrane structures. 
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Interaction partners  Subcellular structure   Presumed functions 
Anillin, actin, myosin  Contractile ring, actin stress fibers Unknown 
SA-RhoGEF, rhotekin  Actin stress fibers   Organization 
Borgs    Unknown    Unknown 
Tubulins?   Microtubules    Unknown 
MAP4    Cytoplasm    Sequestration 
CENP-E   Kinetochore microtubules  Scaffold for kinetochore 
motors? 
Syntaxins/SNARE complex Nerve terminal, platelet granule  Scaffold, sequestration? 
Glutamate transporter  Glial cortex    Regulation? 
Unknown   Spermatozoon annulus   Structural support, diffusion 
barrier? 
Hyperphosphorylated, 
polymerized tau  Neurofibrillary tangles   Incidental adsorption or 
sequestration? 
Polymerized alpha-synuclein Lewy bodies    Incidental adsorption or 
promoting aggregation 
 
Table 2 Described molecular interactions and presumed functions of septin interactions are displayed. 
Hypothesized functions or interaction partner are indicated with a question mark (modified from 
Kinoshita, 2006). 
 
 
To investigate whether MAL function is directly dependent on septins, the septin 
cytoskeleton of MAL-deficient mice was analyzed. These mice display a 
characteristic phenotype in the CNS, where the paranodal loops are destabilized and 
detached from the nodal axolemma (Schaeren-Wiemers et al., 2004). The phenotype 
is due to impaired transport of myelin components or local defects in the architecture 
of the nodal structures. In both cases, impairment of the septin cytoskeleton could 
contribute to some extend to this phenotype. But the composition and abundance of 
the septin cortex in MALnull mice was not altered. To follow this up, Sept6null mice 
were analyzed for a phenotype analogous to the MALnull mice. Sept6-deficient mice 
were already described before (Ono et al., 2005). They have a normal lifespan and 
do not show obvious defects in the CNS. However, earlier studies focused mainly on 
neurons and much less on myelinating glia. EM analysis of optic nerves of Sept6null 
mice showed that the paranodal loops were correctly attached to the nodal axolemma 
and the MALnull phenotype was not evident. 
 
One explanation for the lack of any obvious phenotype in Sept6-deficient mice could 
be that other components of the myelin sheath could compensate for the lack of 
Sept6/MAL interaction. One of the known concerns in the field is that the lack of one 
septin can be compensated by homologous other septins. Indeed, Sept11 - the 
closest homolog of Sept6 - was more abundant in myelin membranes purified from 
Sept6-deficient mouse brains. Increased abundance of Sept11 likely compensates for 
the lack of Sept6 and points to a particular role of Sept6 in myelinating cells, since 
increased abundance of Sept11 was not evident in Sept6null whole brain homogenate 
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(Ono et al., 2005). As a next step, Sept11-deficient mice need to be generated and 
ultimately Sept6/11 double null mice to analyze the functional role of Sept6 and 11 in 
myelination further. 
  
The complexity of septin scaffolds in the central nervous system has already been 
described (Hall et al., 2005), but which septin genes are expressed in myelinating 
cells has not been elucidated yet. The expression pattern of the septin gene family in 
myelinating cells seems to be very complex. It might not surprise that myelinating 
cells express many different septins, and upregulate the whole septin cytoskeleton 
towards differentiation and myelination since the different membrane compartments 
of a myelin sheath are extensive and complex. The major stoechiometric complex in 
both Schwann cells and oligodendrocytes seemed to be Sept2/ 7/ 8. This is in 
contrast to whole brain homogenate where the predominant septin complex seems to 
be Sept2/ 6/ 7 (Kinoshita et al., 2002). Data from other studies identified septin 
scaffolds of different composition in different cells (Blaser et al., 2004; Nagata et al., 
2004). This might indicate that each cell type expresses a unique set of septins, 
which then integrate into the cytoskeleton. The role of Sept8 in myelinating glia, 
therefore, might be interesting since this work also demonstrated that Sept8 
transcription leads to myelin specific splice isoforms. 
 
Co-immunoprecipitation experiments for Sept6 were, first, aimed to verify the 
interaction of Sept6 and MAL from in vivo derived samples, and second, to identify 
further myelin components interacting with septins. But seemingly, it was not possible 
to pull down MAL or other membrane bound myelin proteins by immunoprecipitation 
for Sept6. Possibly, Sept6 was too low abundant in the myelin fractions for co-
immunoprecipitation assays. Alternatively, MAL interacting septin complexes might 
be underrepresented in the total of Sept6 containing complexes. It has also to be 
considered that the interface between septins and transmembrane proteins like MAL 
might be lost upon detergent extraction. Here, Sept2 was the only protein co-
precipitating with Sept6. 
 
Septin function critically depends on heteromeric complex formation. Therefore, co-
immunoprecipitation experiments for Sept2 were performed with the following 
reasoning. Sept2 was shown to interact with Sept6 in myelin fractions. The working 
hypothesis was that Sept6 interactors, like MAL, might be pulled down also together 
with Sept2 if the Sept2/ 6/ X complex was abundant and stable or if also septin 
complexes of other composition interacted with MAL. Sept2 turned out to be 
abundant in CNS myelinated fiber tracts as well as in myelinating Schwann cells. 
Therefore, Sept2 was a good candidate for co-immunoprecipitation assays. Indeed, 
immunoprecipitation for Sept2 led to the purification of multiple septins in CNS myelin 
and PNS homogenates. Sept6 was co-precipitated together with Sept2 verifying their 
interaction in myelin fractions. But, comparable to the immunoprecipitation 
experiments for Sept6, myelin proteins, in particular MAL, were not co-purified. An 
Discussion 
   
97 
explanation could be that the septin/membrane interface was destroyed by detergent 
extraction. 
 
Immunoprecipitation for Sept2 revealed distinct septin complexes interacting with 
myelin membranes, and therefore, the composition of these complexes was analyzed 
by mass spectrometry. Complexes isolated from the CNS and PNS were identical 
with the exception of Sept4, which was only detected in the CNS complex. Both, in 
the CNS and PNS a stoechiometric complex of Sept2, 7 and 8 of relative high 
abundance was found. The other septins were present in non-stoechiometric 
quantities. Septin complexes of different composition have been reconstituted and 
analyzed in vitro and served as a model to study septin complex formation. The 
Sept2/ 6/ 7 complex could be expressed and isolated from E.coli (Sheffield et al., 
2003) and insect cells (Kinoshita et al., 2002). This fundamental septin complex 
served as a model for biochemical determination of the rules for septin complexes 
formation. In the Sept2/ 6 /7 complex, replacement of Sept6 with Sept11 lead also to 
a stable complex. Sept2 could be replaced by Sept1, 4 and 5. Sept7 seemed to be 
irreplaceable and fundamental for all septin complexes (Kinoshita, M., C. Field, M.L. 
Coughlin, and T.J. Mitchison. unpublished observations (Kinoshita, 2003a)). 
Kinoshita and colleagues concluded from these data that one septin from the 
subgroup II together with one from subgroup III and Sept7 can form a stable 
canonical complex (see also Figure 12). The role of subgroup I needs still to be 
investigated. Further data suggests that septin preparations from tissue or cells may 
not only consist of canonical complexes but also contain sub-stoechiometric 
quantities of other septins. Here, in myelinating cells, Sept2/ 7/ 8 might be the 
predominant canonical complex both in Schwann cells and oligodendrocytes. In 
addition, complexes such as Sept2/ 6/ 7, Sept2/ 7/ 11 might exist. It was not possible 
to judge by co-immunoprecipitation if these predicted septin complexes exist as 
discrete entities or as mixed scaffolds. The absence of Sept4 in the PNS might point 
to an oligodendrocyte specific function of Sept4, which correlates well with its strong 
upregulation during oligodendrocyte differentiation and its abundance in CNS myelin 
(Werner et al., 2007). 
 
Further characterization of the identified septins interacting with Sept2 showed that all 
of them were associated with myelin membrane fractions. An interesting observation 
was the three transcript variants of Sept8; two of which interacting specifically with 
myelin membranes and a third with plasma membranes either from astrocytes or from 
neurons. This might point to splice variant specific expression or incorporation of 
distinct splice isoforms into different membrane subdomains. In line with this, human 
Sept8 was demonstrated to generate four splice variants and these isoforms showed 
brain region specific expression patterns (Blaser et al., 2004). This molecular as well 
as structural complexity of septin scaffolds is challenging for further analysis of septin 
function, but the data presented in this work provide levers to specifically tackle the 
septin system in myelinating cells. 
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Several studies of the myelin proteome pointed to the presence of septins in myelin 
fractions (Roth, 2006; Taylor et al., 2004; Werner et al., 2007). Still, it was not known 
how septins distribute in oligodendrocytes and Schwann cells and in particular along 
the myelinated internode. In this work, confocal co-localization analysis of septins in 
peripheral teased nerve fiber preparations identified, besides the expected 
cytoplasmic localization of septins (Figure 43A), also an accumulation in particular 
non-compact myelin membrane compartments such as the microvilli, paranodal loops 
and the outer rim of the Schmidt-Lanterman incisures (Figure 43B and C). This is of 
interest because these compartments are believed to be important for protein 
turnover and maintenance of the myelin sheath. It is well-known that septins interact 
with components of the vesicle fusion machineries like the exocyst complex and 
syntaxin (Beites et al., 1999; Hsu et al., 1999; Hsu et al., 1998). It was also 
demonstrated that phosphorylation of Sept5 modulates exocytosis (Amin et al., 
2008). In line with this, septins might have a role in vesicle targeting and 
incorporation into the emerging and adult myelin sheath (Figure 43A and B). Septin 
scaffolds of different composition might determine regions permitted for vesicle fusion 
or even discriminate between vesicles carrying different cargo. It was demonstrated 
that several myelin proteins are sorted and transported into different vesicles (Trapp 
et al., 1995). Septin scaffolds might discriminate between these vesicles by binding to 
distinct myelin proteins, like MAL, enabling fusion with the correct domain. Maybe it is 
worthwhile to mention that MAL was localized in all compartments of the myelin 
sheath in contrast to other myelin proteins which incorporate in one or the other 
compartment. Septins might instruct MAL containing lipid microdomains where to 
incorporate into myelin structures or MAL might direct septin scaffolds to sites of 
membrane addition and recycling. In both way septin/MAL and related complexes 
might be main instructors for membrane trafficking in the myelin sheath. 
The localization of septins in myelinated internodes is intriguing in yet another 
context. In yeast, septins build up distinct membrane subcompartments by 
establishing diffusion barriers that restrict membrane bound structures to respective 
domains (Barral et al., 2000; Luedeke et al., 2005; Takizawa et al., 2000). Up to day 
no septin diffusion barrier was described for mammalian septins but clearly this is a 
major focus of current investigations. Recently, a septin complex of Sept5/ 7/ 11 was 
shown to form a scaffold at the spine necks of hippocampal neurons very similar to 
the situation at the yeast mother-bud neck (Xie et al., 2007). It remains to be 
demonstrated that this septin scaffold serves as a diffusion barrier, but still, these 
data show that septin function might be well conserved from yeast to mammals. Here, 
in myelinated internodes septins localized to the non-compact myelin compartment 
but not to the compact myelin. Therefore, septins might have a role in restricting 
lateral diffusion of membrane bound proteins and lipids enabling separation of the 
different myelin compartments. 
Additionally, septins might link specialized membrane patches to other cytoskeleton 
elements, which might be important for the paranodal loop and microvilli organization 
(Figure 43C). Indeed the highest accumulation of septins was localized to the node of 
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Ranvier. The axonal cytoskeleton clustered at the node of Ranvier is well 
characterized and many key players crucial for structural integrity are known (see 
also Figure 7B). Yet, the counterparts in the Schwann cells are much less 
understood. Unfortunately, the co-immunoprecipitation assay for Sept2 did not pull 
down additional components of the paranodal cytoskeleton or the membrane bound 
interaction partners. In the future, it might be helpful to enrich nodal and paranodal 
components prior to immunoprecipitation to increase the chance of co-precipitating 
septin interaction partners from the nodal compartment. 
 
 
 
 
 
 
 
 
Figure 43 A schematic drawing which illustrates septin scaffolds identified in distinct subdomains of the 
myelin sheath. (A) The pool of septins in the perikaryon of Schwann cells as well as in the Cajal bands 
(not specially indicated) and the cytoplasm channels of the oligodendrocytes might have a role in 
sorting and targeting of myelin components to the emerging and adult myelin sheath. Furthermore, 
septin scaffolds are detected in the outer rim of the Schmidt-Lanterman incisures (B) as well as in the 
paranodal loops and the microvilli at the nodes of Ranvier (C) where they might contribute to 
subdomain formation and protein turnover. 
Discussion 
   
100 
The last part of this study focused on functional experiments to study the role of 
septins in myelinating cells. From the Sept6null mice, it was evident that no phenotype 
on myelination was resulting from Sept6 loss. This seemed to be due to functional 
compensation by Sept11. Comparably, downregulation of Sept2 in the DRG/ 
Schwann cell co-cultures using RNA interference did not lead to a phenotype. Here, 
e.g. Sept5, which we showed to be expressed by Schwann cells, might compensate 
for the loss of Sept2. Induced downregulation of Sept7, however, led to vital effects 
on Schwann cell survival. This might suggest that the septin cytoskeleton is essential 
for glial cell development but also prevented the exact definition of the developmental 
step(s) at which it is required. In fact, this study demonstrated that the mouse DRG/ 
Schwann cell co-culture system might not be ideal to analyze effects of targeting 
septins. In the first place, the mouse DRG/ Schwann cell co-culture system was 
chosen because respective target sequences for Sept2 and Sept7 RNAi were 
available. Furthermore, it was planed to use myelinating co-cultures generated from 
GFP-MAG expressing mice. This transgenic mouse line expresses GFP-tagged MAG 
under the control of the MAG promoter and can be used as an elegant reporter for 
myelination (Erb et al., 2006). However, it became evident that the mouse co-culture 
system had several limitations.  First, the culture had to be maintained for a long 
period of time until myelination takes place. Data from this work showed that the 
Schwann cells expressed septins in all stages of differentiation. Following infection 
and downregulation of the target they had to survive 4-5 weeks in culture until 
myelination was completed. Septins are likely involved in different aspects of 
Schwann cell biology, and therefore, successful targeting of the septin cytoskeleton 
might lead to myelin unspecific effects as seen for downregulation of Sept7. Second, 
the myelination efficiency in mouse cultures was low, hindering the analysis of subtle 
effects tremendously. Third, the infection efficiency was dependant on the rate of 
proliferation. Therefore, the infection efficiency varied among different cultures and 
even among different regions of the cover slips depending on the initial local cell 
density. Seemingly, it would be helpful to use rat myelinating cultures. There, 
Schwann cells can be isolated and cultured separately from the DRG neurons, a 
method which could not be established as a reliable standard protocol in the mouse 
system yet. The rat Schwann cells are, therefore, much easier to manipulate with 
retroviral constructs and much higher infection and myelination efficiencies can be 
obtained. 
 
To circumvent compensation mechanisms seen both in the Sept6null mouse and for 
Sept2 RNA interference a dominant negative mutant approach was performed on 
myelinating co-cultures. Several dominant negative mutants for Sept2 were already 
described and successfully used (Schmidt and Nichols, 2004; Vega and Hsu, 2003). 
Here, a dominant negative Sept2 mutant impairing the GTP binding was analyzed 
regarding effects on myelination. The mutant protein was tagged with the red 
fluorescent protein mCherry for infection control and protein visualization. The tagged 
wild type Sept2 protein, used as a negative control, localized analogous to 
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endogenous septin and no protein aggregates were formed. This is remarkable since 
we showed earlier that expression of GFP tagged Sept2, Sept6 or Sept7 led to 
aggregates in COS7 cells and in Oli-Neu cells (Buser, Masterthesis, 2003). 
Therefore, this new C-terminal tagged Sept2 construct seemed to be favorable in 
terms of protein localization. Indeed, the wild type Sept2-mCherry construct could 
also be further used for live imaging experiments to analyze septin dynamics in living 
cells. Here, DRG/ Schwann cell co-cultures were infected with constructs expressing 
either the wild type Sept2-mCherry or the dominant negative Sept2 mutation fused to 
mCherry. Unfortunately, the infection efficiency in the DRG/ Schwann cell co-cultures 
was highly variable comparable to the situation with the RNAi constructs. 
Furthermore, the expression level of tagged Sept2 in the myelinated internode was 
low, complicating the identification of infected cells. Therefore, it was not possible to 
analyze the effect of the dominant negative Sept2 mutation in myelinating Schwann 
cells. In the future, it might be favorable to use bicistronic vectors expressing GFP 
and mCherry tagged Sept2 separately to robustly identify infected cells. Comparably 
to the RNAi analysis, the use of rat myelinating cultures might facilitate the 
identification of effects of the dominant negative mutants on septin function. 
 
In summary, this study showed that myelinating glial cells express a distinct set of 
septins at all stages of differentiation. Remarkably, they upregulate many 
components of the septin cytoskeleton in the period of high myelinating activity. It 
was further shown that discrete septin complexes interact with myelin membranes. 
Septins may form specialized scaffolds in non-compact myelin compartments (Figure 
43) and the investigation of these scaffolds might reveal new cytoskeleton interactors 
in myelinating glia. The difficulties of tackling the septin system are well known. The 
redundancy among different septins complicates the analysis of septin function 
tremendously. All attempts to generate null-mutant animals led to very mild 
impairments with respect to brain development and function (Fujishima et al., 2007; 
Ihara et al., 2005; Kissel et al., 2005; Ono et al., 2005; Peng et al., 2002). Therefore, 
in the future, it may be necessary to generate inducible tissue specific mutants to 
circumvent compensation mechanisms.  
 
In conclusion, septins are very intriguing in their ability to influence all other 
cytoskeleton systems and to organize membrane structures. Their further study will 
undoubtly lead to a better understanding how complex membrane structures are 
building up and maintained in development and in the adult. 
 
 
 
Outlook 
   
102 
9 Outlook 
This work was the first comprehensive study of septins in oligodendrocytes and 
Schwann cells. The data open up new perspectives for future studies on the function 
of septins in myelin. 
First, the expression analysis revealed which septins are expressed in myelinating 
cells and how they are regulated during differentiation and myelination. These data 
are important since the knowledge of the exact composition of the septin cortex at a 
given time point is crucial to understand generated phenotypes or the absence of any 
effect upon targeting of septins. This study indicates that the septin cortex in 
myelinating cells might be very robust which might be due to compensation 
mechanisms among homologous septins. Still, the data presented here provide 
levers how to overcome this redundancy. In the future, it might be promising to work 
with double knockouts or perform RNA interference on a double null cell culture 
system to completely block the expression of septins from a given subgroup. In line 
with this, it might be interesting to target Sept11 in the Sept6-deficient mouse either 
by using a Sept11-deficient mouse or by downregulating Sept11 by RNA 
interference. If this does not produce an effect on myelination the next step would be 
to target Sept8 on a Sept6/Sept11 double null background since Sept8 might 
compensate the loss of Sept6/11. These experiments are very complex and time 
consuming but, still, they might be necessary to circumvent compensation 
mechanisms as described in this work. Alternatively, it would be interesting to study 
the effect of downregulating individual septins in the rat myelinating DRG/ Schwann 
cell co-culture system since those cultures myelinate much more efficiently and 
quantitatively than the mouse system used here. There, it might be possible to detect 
and analyze subtle defects of myelination after septin targeting. 
Another interesting route will undoubtly be the use of dominant negative septin 
mutants. Unfortunately, in this study we were not successful using these mutants 
since the expression level of the retroviral constructs was to low to generate a robust 
phenotype. Using a stronger promoter, such as the CMV promoter, should overcome 
this problem. Especially, the use of primary oligodendrocyte cultures might be very 
promising since these cells differentiate rapidly in culture and a dominant negative 
phenotype could be analyzed without generating myelin unspecific effects on 
cytokinesis. Analyzing an impact on the cytoskeleton or the myelin membrane 
structuring should be straightforward in oligodendrocyte cultures. 
In line with this, it would be interesting to generate transgenic animals expressing a 
dominant negative septin mutant under the control of a myelin promoter like the 
CNPase promoter or the MAG promoter. This mouse line would start to express the 
septin mutant after proliferation of the Schwann cells or oligodendrocytes 
respectively. Therefore, it might be possible to selectively generate a phenotype on 
myelination or myelin maintenance avoiding unspecific cytokinesis defects. 
Another very promising attempt to study septin function in myelinated internodes 
would be to generate a floxed Sept7 mouse. Then, Schwann cell specific myelin 
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promoters like the P0 promoter could be used to inactivate Sept7 by Cre 
recombinase after Schwann cell proliferation and migration. As mentioned, no 
compensation would be expected since there are no homolog’s to Sept7. 
Additionally, using the established P0-CreERT tamoxifen inducible mouse line, Sept7 
could be deleted after myelination has completed and the effect of Sept7 loss could 
be studied on the mature myelinated internode.  
Undoubtly, it is not easy to target the septin cytoskeleton. All attempts to tackle 
septins by deletion mutants were either lethal or ineffective. Still, targeting septins 
which are known to be expressed late during differentiation like Sept4 in 
oligodendrocytes or controlling the timing of interference will lead to insights into 
septin function in myelinating cells. Septins are very intriguing in terms of their 
interplay with myelin membranes. Their future analysis will lead to a better 
understanding how the myelinating cells are able to build up one of the most complex 
structures in nature, the myelin sheath. 
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